##FILTER=off-target=Variant marked as 'off-target'.
##ANALYSISTYPE=GERMLINE_MULTISAMPLE
##PIPELINE=megSAP 0.1-893-ga055b8e
##SAMPLE=<ID=GS140127_01,Gender=male,ExternalSampleName=131787,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##SAMPLE=<ID=GS140550_01,Gender=male,ExternalSampleName=131751,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##SAMPLE=<ID=GS140549_01,Gender=female,ExternalSampleName=131752,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##DESCRIPTION=GS140127_01=genotype of sample GS140127_01
##DESCRIPTION=GS140550_01=genotype of sample GS140550_01
##DESCRIPTION=GS140549_01=genotype of sample GS140549_01
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=coding_and_splicing_refseq=Coding and splicing details based on RefSeq (Gene, RefSeq id, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=fathmm-MKL=fathmm-MKL score (for coding/non-coding regions). Deleterious threshold > 0.5.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=GeneSplicer=GeneSplicer splicing prediction (state/type/coordinates/confidence/score).
##DESCRIPTION=dbscSNV=dbscSNV splicing prediction (ADA/RF score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=MMSplice_DeltaLogitPSI=MMsplice delta Logit PSI score: variant's effect on the exon inclusion - positive score shows higher exon inclusion, negative higher exclusion rate. A score greater than 2 or less than -2 can be considered strong.
##DESCRIPTION=MMSplice_pathogenicity=MMsplice pathogenicity score: probability of pathogenic effect of the variant on splicing
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=gene_blacklist=The gene(s) are contained on the blacklist of unreliable genes.
#chr	start	end	ref	obs	GS140127_01	GS140550_01	GS140549_01	filter	quality	gene	variant_type	coding_and_splicing	coding_and_splicing_refseq	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	phyloP	Sift	PolyPhen	fathmm-MKL	CADD	REVEL	MaxEntScan	GeneSplicer	dbscSNV	COSMIC	MMSplice_DeltaLogitPSI	MMSplice_pathogenicity	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	957898	957898	G	T	hom	het	hom	off-target	QUAL=3685;DP=63,55,45;AF=0.98,0.64,1.00;MQM=60;SAP=302;ABP=11	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:intron2/35:c.463+56G>T::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2799064	0.3285	0.3627	2084,.		-2.0720			0.00,0.12							-0.26459811417403506	0.14764630911973206	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	977330	977330	T	C	hom	hom	hom		QUAL=1743;DP=13,26,20;AF=1.00,1.00,1.00;MQM=60;SAP=84;ABP=0	AGRN	splice_region&intron	AGRN:ENST00000379370:splice_region_variant&intron_variant:LOW:intron6/35:c.1178-6T>C::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128292 [benign DISEASE=not specified];			rs2799066	0.8852	0.9233	12149,.	0.7112,0.9515,0.9998,0.9180,0.9530	-0.8450			0.01,0.17			6.81>6.95		0.000/0.002		0.1949290344175371	0.08690561938602366	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	977570	977570	G	A	hom	hom	hom	off-target	QUAL=1504;DP=17,21,15;AF=1.00,1.00,1.00;MQM=60;SAP=101;ABP=0	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:intron7/35:c.1384+28G>A::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263159 [benign DISEASE=not specified];			rs2710876	0.7941	0.8973	10585,.	0.4355,0.9316,0.9726,0.9149,0.9451	-1.5510			0.03,0.18							-0.11453611729631365	0.19709442113573897	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	978604	978605	CT	-	wt	het	wt	off-target	QUAL=1582;DP=60,194,167;AF=0.00,0.49,0.00;MQM=60;SAP=147;ABP=3	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:intron7/35:c.1385-15_1385-14del::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263160 [benign DISEASE=not specified];			rs35881187	0.4792	0.5514	3578,.	0.0943,0.6972,0.7858,0.5385,0.5463	0.0350										-0.7169694303724746	0.8160656087946528	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	981087	981087	A	G	hom	hom	hom	off-target	QUAL=5679;DP=66,65,51;AF=1.00,1.00,1.00;MQM=59;SAP=3;ABP=0	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:intron14/35:c.2537-26A>G::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263172 [benign DISEASE=not specified];			rs3128098	0.8694	0.9206	11837,.	0.6365,0.9462,0.9999,0.9247,0.9552	-0.5730			0.04,0.15							-0.49865708375400813	0.3100323510073696	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	981931	981931	A	G	hom	hom	hom		QUAL=6156;DP=49,96,70;AF=1.00,1.00,1.00;MQM=60;SAP=5;ABP=0	AGRN	synonymous	AGRN:ENST00000379370:synonymous_variant:LOW:exon18/36:c.3066A>G:p.Ser1022=:			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128297 [benign DISEASE=not specified];			rs2465128		0.8865	10697,.	0.4974,0.9296,0.9677,0.9059,0.8885	-1.7540			0.02,0.07							0.014937753979081736	0.3182585968250821	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	982941	982941	T	C	hom	hom	hom	off-target	QUAL=9172;DP=47,149,105;AF=1.00,1.00,1.00;MQM=60;SAP=55;ABP=0	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:intron20/35:c.3517-12T>C::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263181 [benign DISEASE=not specified];			rs3128102		0.8963	10707,.	0.4469,0.9319,0.9726,0.9133,0.9443	0.1090			0.03,0.17			6.84>6.29		0.000/0.014		-0.20947478355411708	0.6926272788450626	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	982994	982994	T	C	hom	hom	hom		QUAL=15338;DP=135,208,143;AF=0.99,1.00,1.00;MQM=59;SAP=13;ABP=0	AGRN	synonymous	AGRN:ENST00000379370:synonymous_variant:LOW:exon21/36:c.3558T>C:p.Phe1186=:PF01390 [SEA domain]			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128302 [benign DISEASE=not specified];			rs10267	0.8359	0.9083	11210,.	0.5251,0.9388,0.9995,0.9167,0.9527	0.5010			0.09,0.93							0.16946554442140582	0.7005338938609648	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	984302	984302	T	C	het	hom	wt		QUAL=574;DP=9,19,17;AF=0.67,1.00,0.00;MQM=60;SAP=7;ABP=5	AGRN	synonymous	AGRN:ENST00000379370:synonymous_variant:LOW:exon24/36:c.4161T>C:p.Thr1387=:		regulatory_region_variant:open_chromatin_region	103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128307 [benign DISEASE=not specified];			rs9442391	0.5457	0.5883	4023,.	0.2729,0.7050,0.8196,0.5652,0.5594	-1.1240			0.01,0.16							-0.04935716542215145	0.30472592316355274	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	985266	985266	C	T	het	hom	wt	off-target	QUAL=583;DP=8,20,11;AF=0.50,1.00,0.00;MQM=60;SAP=3;ABP=3	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:intron26/35:c.4745-17C>T::		regulatory_region_variant:open_chromatin_region	103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263188 [benign DISEASE=not specified];			rs2275813	0.4952	0.5575	3542,.	0.1480,0.7111,0.8103,0.5353,0.5454	1.9730			0.19,0.18			11.49>11.28				0.445488375204877	0.14981607034424083	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	985444	985444	G	-	hom	wt	hom	off-target	QUAL=382;DP=4,6,10;AF=0.75,0.50,1.00;MQM=60;SAP=11;ABP=0	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:intron27/35:c.4879+41del::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs774490460		0.5598	3743,.	0.7422,0.5306,0.6485,0.4549,0.4871	0.1170										-0.0041130850431583795	0.38032167466709066	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	985449	985449	G	A	wt	hom	wt	off-target	QUAL=382;DP=4,6,10;AF=0.75,0.50,1.00;MQM=60;SAP=3;ABP=0	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:intron27/35:c.4879+32G>A::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263192 [benign DISEASE=not specified];			rs2799067	0.5256	0.5832	2268,.	0.2618,0.5481,0.5050,0.6172,0.6162	0.1530			0.03,0.07							-0.08399203465433147	0.38110637532523317	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	985450	985450	G	A	hom	wt	hom	off-target	QUAL=382;DP=4,6,10;AF=0.75,0.50,1.00;MQM=60;SAP=11;ABP=0	AGRN	intron	AGRN:ENST00000379370:intron_variant:MODIFIER:intron27/35:c.4879+33G>A::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs397834473	0.4465	0.5096	3832,.	0.6971,0.4836,0.6056,0.4288,0.4499	-0.4470			0.15,0.26							-0.0480088727770237	0.3807528132091395	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	987200	987200	C	T	hom	hom	hom		QUAL=10516;DP=63,150,134;AF=0.97,0.99,1.00;MQM=60;SAP=112;ABP=0	AGRN	splice_region&intron	AGRN:ENST00000379370:splice_region_variant&intron_variant:LOW:intron33/35:c.5651+5C>T::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128317 [benign DISEASE=not specified];			rs9803031		0.8871	10698,.	0.4387,0.9320,0.9957,0.9082,0.8828	-0.9360			0.02,0.14			9.65>8.73		0.000/0.016		-0.3906931174998692	0.4171535938228813	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990280	990280	C	T	wt	het	het		QUAL=4766;DP=101,207,174;AF=0.00,0.59,0.51;MQM=60;SAP=308;ABP=11	AGRN	synonymous	AGRN:ENST00000379370:synonymous_variant:LOW:exon36/36:c.6057C>T:p.Asp2019=:PF00054 [Laminin G domain]		regulatory_region_variant:CTCF_binding_site	103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	128319 [benign DISEASE=not specified];			rs4275402		0.6764	5782,.	0.3114,0.7722,0.8138,0.6980,0.6133	-0.7110			0.35,0.88							-0.01513531898925211	0.9415636459494688	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990380	990380	C	T	hom	het	het		QUAL=12409;DP=162,432,332;AF=0.98,0.49,0.44;MQM=60;SAP=131;ABP=9	AGRN	3'UTR	AGRN:ENST00000379370:3_prime_UTR_variant:MODIFIER:exon36/36:c.*19C>T::		regulatory_region_variant:CTCF_binding_site	103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];	263157 [benign DISEASE=not specified];			rs3121561	0.3434	0.3621	2197,.	0.5233,0.2137,0.1794,0.2920,0.3087	-0.1240			0.05,0.09							-0.007546207230164329	0.9416506386897916	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990417	990417	T	C	hom	het	het		QUAL=16506;DP=185,502,389;AF=0.99,0.49,0.46;MQM=60;SAP=14;ABP=7	AGRN,RP11-54O7.14	3'UTR,non_coding_transcript_exon	AGRN:ENST00000379370:3_prime_UTR_variant:MODIFIER:exon36/36:c.*56T>C::,RP11-54O7.14:ENST00000418300:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.5T>C::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2465136	0.3840	0.3941	2699,.		0.3020			0.78,0.96							0.12718192713940552	0.9419822719830643	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990517	990517	C	T	hom	hom	het		QUAL=18325;DP=120,372,285;AF=0.99,1.00,0.48;MQM=60;SAP=200;ABP=4	AGRN,RP11-54O7.14	3'UTR,non_coding_transcript_exon	AGRN:ENST00000379370:3_prime_UTR_variant:MODIFIER:exon36/36:c.*156C>T::,RP11-54O7.14:ENST00000418300:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.105C>T::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2710872	0.9179	0.8773	12103,.		-0.4100			0.04,0.14							-0.09201603195828403	0.9415937823412913	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990773	990773	C	T	hom	hom	het		QUAL=22302;DP=180,404,296;AF=1.00,1.00,0.54;MQM=60;SAP=88;ABP=6	AGRN,RP11-54O7.14	3'UTR,intron&non_coding_transcript	AGRN:ENST00000379370:3_prime_UTR_variant:MODIFIER:exon36/36:c.*412C>T::,RP11-54O7.14:ENST00000418300:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.183+178C>T::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2799072	0.8460	0.8187	10690,.		-0.5960			0.05,0.13							-0.004386291190450805	0.9416868244553815	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990806	990806	G	A	hom	hom	het		QUAL=24526;DP=222,450,312;AF=0.98,1.00,0.54;MQM=60;SAP=59;ABP=7	AGRN,RP11-54O7.14	3'UTR,intron&non_coding_transcript	AGRN:ENST00000379370:3_prime_UTR_variant:MODIFIER:exon36/36:c.*445G>A::,RP11-54O7.14:ENST00000418300:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.183+211G>A::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs2799073		0.8188	10688,.		-0.1840			0.06,0.14							0.02747336672233574	0.9420504908207213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	990984	990984	G	A	hom	hom	het		QUAL=15841;DP=146,273,190;AF=1.00,1.00,0.59;MQM=59;SAP=268;ABP=16	AGRN,RP11-54O7.14	3'UTR,intron&non_coding_transcript	AGRN:ENST00000379370:3_prime_UTR_variant:MODIFIER:exon36/36:c.*623G>A::,RP11-54O7.14:ENST00000418300:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.184-294G>A::			103320 [GENE=AGRN PHENOS=Myasthenic syndrome,congenital,8,with pre- and postsynaptic defects,615120,Autosomal recessive];				rs8014		0.8811	12210,.		-2.5600			0.00,0.06							-0.013699999816612502	0.9415801080997365	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN(inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1956362	1956362	G	A	hom	het	het	off-target	QUAL=6515;DP=81,170,172;AF=1.00,0.48,0.49;MQM=60;SAP=82;ABP=3	GABRD	intron	GABRD:ENST00000378585:intron_variant:MODIFIER:intron1/8:c.69-19G>A::			137163 [GENE=GABRD PHENOS=Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant];	256824 [benign DISEASE=not specified];			rs2376805	0.7756	0.8119	10356,.	0.7935,0.7394,0.7174,0.8311,0.7722	-0.2280			0.00,0.15			7.68>6.22				-0.5396885969916893	0.5014270852338876	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD(inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	1957037	1957037	T	C	het	het	wt		QUAL=6704;DP=159,399,341;AF=0.53,0.49,0.00;MQM=59;SAP=72;ABP=3	GABRD	synonymous	GABRD:ENST00000378585:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain]			137163 [GENE=GABRD PHENOS=Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant];	256823 [benign DISEASE=not specified,not provided];			rs2229110	0.5613	0.6469	6668,.	0.7305,0.4736,0.3137,0.6572,0.4740	-1.3800			0.07,0.88							0.06310156766076615	0.08327864061448527	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD(inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	1957220	1957220	G	-	het	het	wt	off-target	QUAL=1338;DP=56,79,56;AF=0.52,0.49,0.00;MQM=60;SAP=150;ABP=3	GABRD	intron	GABRD:ENST00000378585:intron_variant:MODIFIER:intron4/8:c.470+45del::			137163 [GENE=GABRD PHENOS=Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant];				rs3831907	0.1080	0.1196	281,.	0.2114,0.0549,0.0248,0.1141,0.0777	-4.7340										-0.22453561759178586	0.08300134236913473	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD(inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	1960674	1960674	C	T	het	wt	het		QUAL=4896;DP=119,386,266;AF=0.50,0.01,0.56;MQM=59;SAP=19;ABP=8	GABRD	synonymous	GABRD:ENST00000378585:synonymous_variant:LOW:exon7/9:c.816C>T:p.Ser272=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region]			137163 [GENE=GABRD PHENOS=Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant];	256825 [benign DISEASE=not specified];			rs28408173	0.1983	0.1918	416,.	0.0319,0.2378,0.4717,0.1428,0.2543	-0.7780			0.10,0.96							-0.1810814608754079	0.15194481533379434	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD(inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	1961408	1961408	C	T	het	wt	het	off-target	QUAL=1606;DP=69,74,64;AF=0.57,0.01,0.50;MQM=59;SAP=42;ABP=4	GABRD	intron	GABRD:ENST00000378585:intron_variant:MODIFIER:intron8/8:c.1060-14C>T::			137163 [GENE=GABRD PHENOS=Epilepsy,generalized,with febrile seizures plus,type 5,susceptibility to,613060,Autosomal dominant/Epilepsy,idiopathic generalized,10,613060,Autosomal dominant/Epilepsy,juvenile myoclonic,susceptibility to,613060,Autosomal dominant];	256822 [benign DISEASE=not specified];			rs28431879	0.1999	0.1856	434,.	0.0295,0.2369,0.4852,0.1366,0.2428	-1.4010			0.00,0.11			7.61>6.94				0.273194692283962	0.682682636168994	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD(inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2337277	2337277	C	T	het	n/a	n/a		QUAL=107;DP=20,1,1;AF=0.40,0.00,0.00;MQM=60;SAP=20;ABP=4	PEX10	splice_region&intron,intron	PEX10:ENST00000288774:splice_region_variant&intron_variant:LOW:intron5/5:c.973-4G>A::,PEX10:ENST00000447513:splice_region_variant&intron_variant:LOW:intron5/5:c.913-4G>A::,PEX10:ENST00000507596:intron_variant:MODIFIER:intron5/5:c.913-10G>A::		regulatory_region_variant:promoter_flanking_region	602859 [GENE=PEX10 PHENOS=Peroxisome biogenesis disorder 6A (Zellweger),614870,Autosomal recessive/Peroxisome biogenesis disorder 6B,614871,Autosomal recessive];	262791 [benign/likely benign DISEASE=Zellweger syndrome,not specified,not provided];			rs11586985	0.0809	0.1050	168,.	0.0217,0.0584,0.1222,0.1219,0.1099	-1.9740			0.08,0.13			13.68>13.46,-18.79>-18.77		0.000/0.002		0.0347656770139328	0.9875060162192942	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1(inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10(inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2338126	2338126	C	A	wt	het	het	off-target	QUAL=1048;DP=46,55,45;AF=0.00,0.49,0.49;MQM=60;SAP=30;ABP=3	PEX10	intron	PEX10:ENST00000288774:intron_variant:MODIFIER:intron4/5:c.836+33G>T::,PEX10:ENST00000447513:intron_variant:MODIFIER:intron4/5:c.776+33G>T::,PEX10:ENST00000507596:intron_variant:MODIFIER:intron4/5:c.776+33G>T::		regulatory_region_variant:CTCF_binding_site	602859 [GENE=PEX10 PHENOS=Peroxisome biogenesis disorder 6A (Zellweger),614870,Autosomal recessive/Peroxisome biogenesis disorder 6B,614871,Autosomal recessive];				rs3795269	0.3391	0.4016	2574,.	0.2892,0.4078,0.2649,0.4329,0.3642	0.5730			0.20,0.15							0.03706580888385731	0.8775400976506444	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1(inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10(inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2340200	2340200	T	C	wt	het	het		QUAL=985;DP=43,48,39;AF=0.02,0.54,0.44;MQM=60;SAP=47;ABP=3	PEX10	synonymous	PEX10:ENST00000288774:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region],PEX10:ENST00000447513:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region],PEX10:ENST00000507596:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region]			602859 [GENE=PEX10 PHENOS=Peroxisome biogenesis disorder 6A (Zellweger),614870,Autosomal recessive/Peroxisome biogenesis disorder 6B,614871,Autosomal recessive];	129884 [benign DISEASE=Zellweger syndrome,not specified,not provided];			rs2494598		0.7735	8639,.	0.5917,0.7710,0.7184,0.8112,0.7245	-6.5230			0.03,0.05							0.11390319542090828	0.9117560897494592	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1(inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10(inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	5922834	5922834	C	A	het	hom	wt	off-target	QUAL=1543;DP=54,42,26;AF=0.37,1.00,0.00;MQM=60;SAP=129;ABP=10	NPHP4,MIR4689	downstream_gene,upstream_gene	NPHP4:ENST00000378156:downstream_gene_variant:MODIFIER::::,MIR4689:ENST00000582517:upstream_gene_variant:MODIFIER::::							rs12133533	0.0966	0.1249	305,.	0.0152,0.0833,0.0529,0.1640,0.1101	-0.3700			0.06,0.16									n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689(inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5926507	5926507	T	C	het	hom	wt		QUAL=8832;DP=275,182,155;AF=0.49,0.99,0.00;MQM=60;SAP=28;ABP=3	NPHP4	synonymous	NPHP4:ENST00000378156:synonymous_variant:LOW:exon26/30:c.3570A>G:p.Glu1190=:		regulatory_region_variant:open_chromatin_region	607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	95683 [benign DISEASE=Nephronophthisis,Renal dysplasia and retinal aplasia,not specified];			rs555164	0.3197	0.3926	2149,.	0.2002,0.3706,0.2558,0.4222,0.4302	0.2880			0.02,0.92							0.09464556604856729	0.9444737731615913	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689(inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5927031	5927031	A	G	het	hom	wt	off-target	QUAL=3708;DP=80,96,66;AF=0.48,1.00,0.00;MQM=60;SAP=152;ABP=3	NPHP4	intron	NPHP4:ENST00000378156:intron_variant:MODIFIER:intron25/29:c.3558+59T>C::			607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];				rs12122135	0.1028	0.1260	296,.		-0.2430			0.02,0.10							-0.1238557752319287	0.4255229727515018	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689(inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5927943	5927943	G	A	wt	het	wt		QUAL=3628;DP=131,360,269;AF=0.00,0.48,0.00;MQM=60;SAP=46;ABP=4	NPHP4	missense	NPHP4:ENST00000378156:missense_variant:MODERATE:exon24/30:c.3329C>T:p.Ala1110Val:			607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	95682 [likely benign(replaced by megSAP based on classifications:1x1,1x2,3x3) DISEASE=Nephronophthisis,Renal dysplasia and retinal aplasia,not specified];	CM125782 [CLASS=DM MUT=ALT PHEN="Cardiovascular malformations" GENE=NPHP4];		rs139767853	0.0014	0.0037	0,.	0.0012,0.0030,0.0000,0.0060,0.0008	0.0280	T(0.55)	B(0.01)	0.08,0.26		0.32		gain/donor/5927942-5927943/Medium/6.530789			-0.12628178661266	0.21688092296606998	1	70	0 / 0					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5934490	5934490	A	G	hom	hom	het	off-target	QUAL=5950;DP=74,112,68;AF=0.99,1.00,0.49;MQM=60;SAP=476;ABP=3	NPHP4	intron	NPHP4:ENST00000378156:intron_variant:MODIFIER:intron22/29:c.3231+41T>C::			607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	260554 [benign DISEASE=not specified];			rs868163	0.5693	0.6453	6624,.	0.7125,0.4989,0.2688,0.6436,0.6148	-3.6260			0.01,0.09							-0.08880899445030375	0.310842246151737	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5935162	5935162	A	T	het	het	hom		QUAL=4956;DP=87,128,87;AF=0.38,0.52,1.00;MQM=60;SAP=289;ABP=5	NPHP4	splice_acceptor	NPHP4:ENST00000378156:splice_acceptor_variant:HIGH:intron20/29:c.2818-2T>A::			607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	167375 [benign DISEASE=not specified];			rs1287637		0.8606	11601,.	0.8938,0.7936,0.8101,0.8244,0.8282	0.4530			0.00,0.85			0.90>9.27	gain/acceptor/5935162-5935163/High/14.274034			2.9078353637063747	5.398016961224775	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5937391	5937391	C	T	n/a	hom	wt	off-target	QUAL=157;DP=1,4,87;AF=1.00,1.00,1.00;MQM=60;SAP=6;ABP=0	NPHP4	intron	NPHP4:ENST00000378156:intron_variant:MODIFIER:intron19/29:c.2612-33G>A::			607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	260547 [benign DISEASE=not specified];			rs3747989		0.8299	10876,.	0.9382,0.7305,0.8517,0.8010,0.7363	-2.2310			0.00,0.05							-0.16598922874828542	0.8784548600684099	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5947308	5947308	G	A	wt	het	wt	off-target	QUAL=1780;DP=130,187,146;AF=0.00,0.42,0.01;MQM=60;SAP=88;ABP=12	NPHP4	intron	NPHP4:ENST00000378156:intron_variant:MODIFIER:intron18/29:c.2485+38C>T::			607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	260546 [benign DISEASE=not specified];			rs41280814	0.0863	0.1342	259,.	0.0275,0.0789,0.0795,0.1716,0.1155	-1.8090			0.05,0.17							0.12713952257017136	0.13856098624740254	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5965381	5965381	C	T	wt	het	wt		QUAL=2692;DP=208,262,206;AF=0.00,0.43,0.00;MQM=60;SAP=34;ABP=14	NPHP4	synonymous	NPHP4:ENST00000378156:synonymous_variant:LOW:exon15/30:c.1926G>A:p.Glu642=:			607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	95673 [benign/likely benign DISEASE=Nephronophthisis,Renal dysplasia and retinal aplasia,not specified];			rs12120967	0.0841	0.1317	259,.	0.0271,0.0767,0.0768,0.1672,0.1125	-0.7650			0.03,0.33							-0.28205598018227884	0.2799232067183801	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5987696	5987696	T	C	wt	het	wt	off-target	QUAL=2405;DP=136,184,150;AF=0.00,0.54,0.02;MQM=60;SAP=33;ABP=5	NPHP4	intron	NPHP4:ENST00000378156:intron_variant:MODIFIER:intron11/29:c.1441+13A>G::			607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];	95671 [benign/likely benign DISEASE=Nephronophthisis,Renal dysplasia and retinal aplasia,not specified];			rs7520105	0.1412	0.1688	428,.	0.2101,0.0876,0.0770,0.1681,0.1150	0.8260			0.31,0.17							0.31203560662045926	0.00984418962945172	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	6046432	6046432	C	G	wt	het	wt	off-target	QUAL=789;DP=53,52,46;AF=0.00,0.63,0.02;MQM=60;SAP=39;ABP=11	NPHP4	intron	NPHP4:ENST00000378156:intron_variant:MODIFIER:intron1/29:c.-38-45G>C::			607215 [GENE=NPHP4 PHENOS=Nephronophthisis 4,606966,Autosomal recessive/Senior-Loken syndrome 4,606996,Autosomal recessive];				rs1295111	0.3878	0.4104	2658,.		-0.1940			0.09,0.19							-0.07224586628759534	0.4147429243849825	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	6052571	6052571	G	A	wt	het	wt	off-target	QUAL=398;DP=3,39,29;AF=0.00,0.51,0.00;MQM=60;SAP=46;ABP=3	KCNAB2	5'UTR,intron	KCNAB2:ENST00000378097:5_prime_UTR_variant:MODIFIER:exon1/16:c.-330G>A::,KCNAB2:ENST00000378111:intron_variant:MODIFIER:intron1/7:c.-53+955G>A::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site					rs61760765	0.0218	0.0351	27,.		-0.2790			0.16,0.33							-0.0226687152740292	0.024940527234034456	1	25	0 / 0					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78), KCNAB2(inh=AD oe_syn=0.95 oe_mis=0.55 oe_lof=0.18)
chr1	6052581	6052581	G	A	n/a	hom	het	off-target	QUAL=1351;DP=2,34,28;AF=1.00,1.00,0.68;MQM=60;SAP=122;ABP=10	KCNAB2	5'UTR,intron	KCNAB2:ENST00000378097:5_prime_UTR_variant:MODIFIER:exon1/16:c.-320G>A::,KCNAB2:ENST00000378111:intron_variant:MODIFIER:intron1/7:c.-53+965G>A::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site					rs806109		0.8310	10906,.		0.0500			0.10,0.21							0.013710168660991253	0.0251256305745426	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4(inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78), KCNAB2(inh=AD oe_syn=0.95 oe_mis=0.55 oe_lof=0.18)
chr1	6526183	6526183	G	A	het	het	wt		QUAL=374;DP=14,20,5;AF=0.43,0.70,0.00;MQM=59;SAP=6;ABP=5	PLEKHG5,TNFRSF25	3'UTR,5'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::,TNFRSF25:ENST00000351959:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::,TNFRSF25:ENST00000356876:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1440C>T::,TNFRSF25:ENST00000377782:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1440C>T::		regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297904 [benign DISEASE=Distal spinal muscular atrophy];			rs3007417	0.2023	0.1843	1065,.	0.5020,0.0510,0.0004,0.0703,0.0791	-0.6580			0.06,0.14				gain/donor/6526182-6526183/Medium/3.418541			-0.10113012421622002	0.9103230508253771	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6526203	6526210	CGTGCTCT	-	het	het	wt		QUAL=369;DP=11,21,6;AF=0.55,0.67,0.00;MQM=59;SAP=4;ABP=7	PLEKHG5,TNFRSF25	3'UTR,5'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1413_*1420del::,TNFRSF25:ENST00000351959:5_prime_UTR_variant:MODIFIER:exon1/9:c.-43_-36del::,TNFRSF25:ENST00000356876:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1413_*1420del::,TNFRSF25:ENST00000377782:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1413_*1420del::		regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297905 [benign DISEASE=Distal spinal muscular atrophy];			rs45616733	0.2027	0.1839	1053,.	0.4251,0.0464,0.0006,0.0579,0.0691	0.8620										-0.16494611192437192	0.910014869947279	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6526241	6526244	CGCC	-	hom	het	wt		QUAL=315;DP=5,15,3;AF=1.00,0.73,0.00;MQM=60;SAP=3;ABP=10	PLEKHG5,TNFRSF25	3'UTR,5'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1379_*1382del::,TNFRSF25:ENST00000356876:5_prime_UTR_variant:MODIFIER:exon1/10:c.-77_-74del::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1379_*1382del::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1379_*1382del::		regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297906 [benign DISEASE=Distal spinal muscular atrophy];			rs45542640	0.2025	0.1838	1069,.		1.0930										0.22695395154045833	0.9106660321903349	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6526319	6526319	C	T	het	het	wt		QUAL=293;DP=31,33,30;AF=0.35,0.39,0.00;MQM=60;SAP=55;ABP=11	PLEKHG5	3'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1304G>A::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1304G>A::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1304G>A::		regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297910 [likely benign DISEASE=Distal spinal muscular atrophy];			rs45604837	0.0863	0.0841	157,.		-0.5600			0.05,0.16							-0.0007253048585921422	0.910424779916725	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6526465	6526465	C	G	het	het	wt		QUAL=3430;DP=81,199,150;AF=0.48,0.54,0.00;MQM=60;SAP=113;ABP=4	PLEKHG5	3'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1158G>C::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*1158G>C::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1158G>C::		regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297912 [benign DISEASE=Distal spinal muscular atrophy];		MIR3 (SINE/MIR)	rs2986754	0.2043	0.1816	1155,.		-0.5720			0.01,0.10							0.0014929827676056283	0.9104624876167163	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6527333	6527333	A	G	het	het	wt		QUAL=1564;DP=75,59,53;AF=0.51,0.47,0.00;MQM=60;SAP=3;ABP=3	PLEKHG5	3'UTR	PLEKHG5:ENST00000340850:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377725:3_prime_UTR_variant:MODIFIER:exon22/22:c.*318T>C::,PLEKHG5:ENST00000377728:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377732:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377737:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000377740:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000377748:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000400913:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000400915:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000535355:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::		regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297928 [benign DISEASE=Distal spinal muscular atrophy];			rs14708	0.2670	0.2632	1682,.		2.0370			0.00,0.11							-0.024135397462009264	0.9356067499879636	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6529183	6529185	TCC	-	wt	het	wt		QUAL=667;DP=53,109,66;AF=0.38,0.46,0.05;MQM=60;SAP=35;ABP=4	PLEKHG5	inframe_deletion	PLEKHG5:ENST00000340850:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377725:inframe_deletion:MODERATE:exon19/22:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377728:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377732:inframe_deletion:MODERATE:exon19/21:c.2277_2279del:p.Glu760del:,PLEKHG5:ENST00000377737:inframe_deletion:MODERATE:exon20/22:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377740:inframe_deletion:MODERATE:exon20/22:c.2397_2399del:p.Glu800del:,PLEKHG5:ENST00000377748:inframe_deletion:MODERATE:exon20/22:c.2397_2399del:p.Glu800del:,PLEKHG5:ENST00000400913:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000400915:inframe_deletion:MODERATE:exon20/22:c.2334_2336del:p.Glu779del:,PLEKHG5:ENST00000535355:inframe_deletion:MODERATE:exon19/21:c.2373_2375del:p.Glu792del:,PLEKHG5:ENST00000537245:inframe_deletion:MODERATE:exon20/22:c.2403_2405del:p.Glu802del:,PLEKHG5:ENST00000544978:inframe_deletion:MODERATE:exon20/22:c.2166_2168del:p.Glu723del:		regulatory_region_variant:promoter_flanking_region	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	194979 [benign/likely benign DISEASE=Distal spinal muscular atrophy,not specified];		(TCC)n (Simple_repeat)	rs113541584	0.0972	0.0848	125,.	0.1890,0.0573,0.0085,0.0753,0.0956	0.1060									COSM4590012,COSM4590013,COSM911543	-0.021685945963919793	0.16187641452057533	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6529443	6529443	A	G	het	het	wt		QUAL=9602;DP=320,486,391;AF=0.48,0.48,0.00;MQM=60;SAP=14;ABP=6	PLEKHG5	synonymous	PLEKHG5:ENST00000340850:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377725:synonymous_variant:LOW:exon18/22:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377728:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377732:synonymous_variant:LOW:exon18/21:c.2112T>C:p.Ser704=:,PLEKHG5:ENST00000377737:synonymous_variant:LOW:exon19/22:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377740:synonymous_variant:LOW:exon19/22:c.2232T>C:p.Ser744=:,PLEKHG5:ENST00000377748:synonymous_variant:LOW:exon19/22:c.2232T>C:p.Ser744=:,PLEKHG5:ENST00000400913:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000400915:synonymous_variant:LOW:exon19/22:c.2169T>C:p.Ser723=:,PLEKHG5:ENST00000535355:synonymous_variant:LOW:exon18/21:c.2208T>C:p.Ser736=:,PLEKHG5:ENST00000537245:synonymous_variant:LOW:exon19/22:c.2238T>C:p.Ser746=:,PLEKHG5:ENST00000544978:synonymous_variant:LOW:exon19/22:c.2001T>C:p.Ser667=:			611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	194881 [benign DISEASE=Distal spinal muscular atrophy,not specified];			rs730600	0.2696	0.2647	1701,.	0.5922,0.0937,0.0041,0.1423,0.1761	-0.2200			0.08,0.79							0.1586312830162087	0.08252459984590596	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6530435	6530435	A	G	het	het	wt	off-target	QUAL=1079;DP=39,55,49;AF=0.46,0.53,0.00;MQM=60;SAP=3;ABP=3	PLEKHG5	intron	PLEKHG5:ENST00000340850:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000377725:intron_variant:MODIFIER:intron15/21:c.1681-20T>C::,PLEKHG5:ENST00000377728:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000377732:intron_variant:MODIFIER:intron15/20:c.1792-20T>C::,PLEKHG5:ENST00000377737:intron_variant:MODIFIER:intron16/21:c.1681-20T>C::,PLEKHG5:ENST00000377740:intron_variant:MODIFIER:intron16/21:c.1912-20T>C::,PLEKHG5:ENST00000377748:intron_variant:MODIFIER:intron16/21:c.1912-20T>C::,PLEKHG5:ENST00000400913:intron_variant:MODIFIER:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000400915:intron_variant:MODIFIER:intron16/21:c.1849-20T>C::,PLEKHG5:ENST00000535355:intron_variant:MODIFIER:intron15/20:c.1888-20T>C::,PLEKHG5:ENST00000537245:intron_variant:MODIFIER:intron16/21:c.1918-20T>C::,PLEKHG5:ENST00000544978:intron_variant:MODIFIER:intron16/21:c.1681-20T>C::			611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];				rs2986753	0.1717	0.1803	622,.	0.3429,0.0779,0.0039,0.1301,0.1509	-0.4640			0.01,0.12			7.80>7.76				0.19511452497447673	0.12747172620359357	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6530965	6530965	-	G	hom	hom	hom	off-target	QUAL=6161;DP=43,126,96;AF=0.93,0.99,0.95;MQM=59;SAP=29;ABP=0	PLEKHG5	intron	PLEKHG5:ENST00000340850:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000377725:intron_variant:MODIFIER:intron13/21:c.1393-22dup::,PLEKHG5:ENST00000377728:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000377732:intron_variant:MODIFIER:intron13/20:c.1504-22dup::,PLEKHG5:ENST00000377737:intron_variant:MODIFIER:intron14/21:c.1393-22dup::,PLEKHG5:ENST00000377740:intron_variant:MODIFIER:intron14/21:c.1624-22dup::,PLEKHG5:ENST00000377748:intron_variant:MODIFIER:intron14/21:c.1624-22dup::,PLEKHG5:ENST00000400913:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000400915:intron_variant:MODIFIER:intron14/21:c.1561-22dup::,PLEKHG5:ENST00000535355:intron_variant:MODIFIER:intron13/20:c.1600-22dup::,PLEKHG5:ENST00000537245:intron_variant:MODIFIER:intron14/21:c.1630-22dup::,PLEKHG5:ENST00000544978:intron_variant:MODIFIER:intron14/21:c.1393-22dup::			611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];				rs111312565	1.0000	1.0000	15524,.	1.0000,1.0000,0.9999,1.0000,1.0000											0.17574056304201802	0.15322675011575226	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25(inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6531589	6531589	C	T	het	het	wt		QUAL=1652;DP=36,114,115;AF=0.67,0.45,0.00;MQM=60;SAP=51;ABP=3	PLEKHG5	missense	PLEKHG5:ENST00000340850:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377725:missense_variant:MODERATE:exon12/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377728:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377732:missense_variant:MODERATE:exon12/21:c.1351G>A:p.Ala451Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377737:missense_variant:MODERATE:exon13/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377740:missense_variant:MODERATE:exon13/22:c.1471G>A:p.Ala491Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377748:missense_variant:MODERATE:exon13/22:c.1471G>A:p.Ala491Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000400913:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000400915:missense_variant:MODERATE:exon13/22:c.1408G>A:p.Ala470Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000535355:missense_variant:MODERATE:exon12/21:c.1447G>A:p.Ala483Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000537245:missense_variant:MODERATE:exon13/22:c.1477G>A:p.Ala493Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000544978:missense_variant:MODERATE:exon13/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain]		regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	297959 [likely benign DISEASE=Distal spinal muscular atrophy];			rs74809741	0.0553	0.0579	62,.	0.0889,0.0369,0.0002,0.0593,0.0518	0.6400	T(0.45),T(0.44),T(0.45),T(0.43),T(0.45),T(0.44),T(0.43),T(0.45),T(0.43),T(0.41),T(0.42),T(0.44)	B(0.01),B(0.00),B(0.01),B(0.01),B(0.01),B(0.00),B(0.01),B(0.01),B(0.01),B(0.01),B(0.01),B(0.00)	0.73,0.93		0.04					0.05713060300492027	0.1504298670010027	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6533393	6533393	G	C	het	het	wt		QUAL=479;DP=25,25,19;AF=0.44,0.56,0.00;MQM=60;SAP=57;ABP=3	PLEKHG5	missense	PLEKHG5:ENST00000340850:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377725:missense_variant:MODERATE:exon8/22:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377728:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377732:missense_variant:MODERATE:exon8/21:c.824C>G:p.Thr275Ser:,PLEKHG5:ENST00000377737:missense_variant:MODERATE:exon9/22:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377740:missense_variant:MODERATE:exon9/22:c.944C>G:p.Thr315Ser:,PLEKHG5:ENST00000377748:missense_variant:MODERATE:exon9/22:c.944C>G:p.Thr315Ser:,PLEKHG5:ENST00000400913:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000400915:missense_variant:MODERATE:exon9/22:c.881C>G:p.Thr294Ser:,PLEKHG5:ENST00000535355:missense_variant:MODERATE:exon8/21:c.920C>G:p.Thr307Ser:,PLEKHG5:ENST00000537245:missense_variant:MODERATE:exon9/22:c.950C>G:p.Thr317Ser:,PLEKHG5:ENST00000544978:missense_variant:MODERATE:exon9/22:c.713C>G:p.Thr238Ser:			611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	198895 [benign DISEASE=Distal spinal muscular atrophy,not specified];			rs61741379	0.2857	0.2786	1993,.	0.6445,0.0990,0.0072,0.1406,0.1621	0.8480	T(0.68),T(0.69),T(0.68),T(0.70),T(0.68),T(0.71),T(0.73),T(0.68),T(0.65),T(0.78),T(0.72),T(0.69)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.00,0.17		0.07					-0.018526952365833932	0.163500404336264	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6579521	6579521	G	C	het	het	het		QUAL=3392;DP=121,91,77;AF=0.53,0.52,0.45;MQM=60;SAP=320;ABP=3	PLEKHG5	5'UTR,missense	PLEKHG5:ENST00000377737:5_prime_UTR_variant:MODIFIER:exon1/22:c.-181C>G::,PLEKHG5:ENST00000377740:missense_variant:MODERATE:exon1/22:c.51C>G:p.Ser17Arg:,PLEKHG5:ENST00000377748:missense_variant:MODERATE:exon1/22:c.51C>G:p.Ser17Arg:		regulatory_region_variant:promoter_flanking_region	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];				rs17438786	0.0136	0.0242	10,.	0.0050,0.0165,0.0000,0.0326,0.0176	0.0870	 ,T(0.13),T(0.17)	 ,B(0.01),B(0.07)	0.13,0.49		0.09					-0.0149058155122902	0.07717810838470143	10	400	0 / 0					PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9(inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6579607	6579607	C	T	hom	hom	hom		QUAL=20016;DP=179,270,204;AF=1.00,1.00,1.00;MQM=59;SAP=740;ABP=0	PLEKHG5	5'UTR	PLEKHG5:ENST00000377737:5_prime_UTR_variant:MODIFIER:exon1/22:c.-267G>A::,PLEKHG5:ENST00000377740:5_prime_UTR_variant:MODIFIER:exon1/22:c.-36G>A::,PLEKHG5:ENST00000377748:5_prime_UTR_variant:MODIFIER:exon1/22:c.-36G>A::		regulatory_region_variant:promoter_flanking_region	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];	380860 [benign DISEASE=not specified];			rs1556035	0.7460	0.8595	9987,.	0.5189,0.9267,0.7933,0.8816,0.8645	0.2500			0.07,0.20							0.018910156604438556	0.07768171480922118	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9(inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6579843	6579843	C	T	hom	hom	hom		QUAL=41827;DP=292,585,454;AF=0.99,1.00,1.00;MQM=59;SAP=140;ABP=0	PLEKHG5	5'UTR	PLEKHG5:ENST00000377737:5_prime_UTR_variant:MODIFIER:exon1/22:c.-503G>A::,PLEKHG5:ENST00000377740:5_prime_UTR_variant:MODIFIER:exon1/22:c.-272G>A::,PLEKHG5:ENST00000377748:5_prime_UTR_variant:MODIFIER:exon1/22:c.-272G>A::		regulatory_region_variant:promoter_flanking_region	611101 [GENE=PLEKHG5 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate C,615376,Autosomal recessive/Spinal muscular atrophy,distal,autosomal recessive,4,611067,Autosomal recessive];				rs1010584	0.7354	0.7734	9752,.		-0.5650			0.03,0.20							-0.007868323846543348	0.07728266752363587	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5(inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9(inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	10318652	10318652	C	G	wt	wt	het		QUAL=2875;DP=314,250,229;AF=0.00,0.00,0.50;MQM=60;SAP=4;ABP=3	KIF1B	synonymous	KIF1B:ENST00000263934:synonymous_variant:LOW:exon4/47:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377081:synonymous_variant:LOW:exon3/48:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377083:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377086:synonymous_variant:LOW:exon4/49:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain],KIF1B:ENST00000377093:synonymous_variant:LOW:exon4/21:c.285C>G:p.Ala95=:PF00225 [Kinesin motor domain]			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	129399 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2,not specified];			rs12402052	0.2300	0.2766	1045,.	0.0864,0.3446,0.2917,0.2914,0.2293	0.0540			0.81,0.97							-0.08033865890540529	0.3903004140981745	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10322054	10322054	G	A	wt	wt	het	off-target	QUAL=2022;DP=314,272,179;AF=0.00,0.00,0.46;MQM=60;SAP=9;ABP=5	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:intron5/46:c.429+26G>A::,KIF1B:ENST00000377081:intron_variant:MODIFIER:intron4/47:c.429+26G>A::,KIF1B:ENST00000377083:intron_variant:MODIFIER:intron5/20:c.429+26G>A::,KIF1B:ENST00000377086:intron_variant:MODIFIER:intron5/48:c.429+26G>A::,KIF1B:ENST00000377093:intron_variant:MODIFIER:intron5/20:c.429+26G>A::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs4846209	0.3399	0.3512	1943,.	0.3418,0.3938,0.3671,0.3431,0.2578	0.0780			0.00,0.08							0.09602596706832822	0.09096161262363713	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10327407	10327407	A	T	wt	wt	het	off-target	QUAL=1115;DP=257,131,100;AF=0.00,0.00,0.50;MQM=60;SAP=55;ABP=3	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:intron5/46:c.430-31A>T::,KIF1B:ENST00000377081:intron_variant:MODIFIER:intron4/47:c.430-31A>T::,KIF1B:ENST00000377083:intron_variant:MODIFIER:intron5/20:c.430-31A>T::,KIF1B:ENST00000377086:intron_variant:MODIFIER:intron5/48:c.430-31A>T::,KIF1B:ENST00000377093:intron_variant:MODIFIER:intron5/20:c.430-31A>T::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs12141246	0.3806	0.3770	2249,.	0.4133,0.3974,0.4087,0.3425,0.2575	-1.8450			0.00,0.07							0.2455891074712072	0.06362769705614789	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10328338	10328338	C	T	wt	wt	het	off-target	QUAL=2382;DP=242,187,186;AF=0.00,0.00,0.52;MQM=60;SAP=45;ABP=3	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:intron7/46:c.720+17C>T::,KIF1B:ENST00000377081:intron_variant:MODIFIER:intron6/47:c.720+17C>T::,KIF1B:ENST00000377083:intron_variant:MODIFIER:intron7/20:c.720+17C>T::,KIF1B:ENST00000377086:intron_variant:MODIFIER:intron7/48:c.720+17C>T::,KIF1B:ENST00000377093:intron_variant:MODIFIER:intron7/20:c.720+17C>T::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	260542 [benign DISEASE=not specified];			rs1339458	0.2540	0.2817	1113,.	0.1535,0.3485,0.2906,0.2919,0.2301	-1.1960			0.06,0.15							0.02664343766959224	0.2966589250926208	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10342629	10342629	G	A	wt	het	het	off-target	QUAL=5605;DP=180,224,219;AF=0.01,0.50,0.49;MQM=60;SAP=99;ABP=3	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:intron13/46:c.1296+38G>A::,KIF1B:ENST00000377081:intron_variant:MODIFIER:intron14/47:c.1434+38G>A::,KIF1B:ENST00000377083:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::,KIF1B:ENST00000377086:intron_variant:MODIFIER:intron15/48:c.1434+38G>A::,KIF1B:ENST00000377093:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];			L3 (LINE/CR1)	rs3748576	0.7127	0.7067	8153,.	0.9335,0.7352,0.5293,0.5971,0.6222	-0.7550			0.01,0.13							0.07228987584226187	0.07941567293679248	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10355834	10355834	C	T	wt	wt	het		QUAL=1539;DP=134,158,128;AF=0.01,0.00,0.48;MQM=60;SAP=10;ABP=3	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:intron17/46:c.1639+10C>T::,KIF1B:ENST00000377081:intron_variant:MODIFIER:intron18/47:c.1777+10C>T::,KIF1B:ENST00000377083:intron_variant:MODIFIER:intron17/20:c.1639+10C>T::,KIF1B:ENST00000377086:intron_variant:MODIFIER:intron19/48:c.1777+10C>T::,KIF1B:ENST00000377093:intron_variant:MODIFIER:intron17/20:c.1639+10C>T::		regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	177960 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2,not specified];			rs3753037	0.2640	0.2844	1165,.	0.1871,0.3503,0.2912,0.2920,0.2295	1.0480			0.09,0.20							-0.08369979078933901	0.1355315687289665	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P(inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10357207	10357207	T	-	wt	het	wt	off-target	QUAL=196;DP=183,243,171;AF=0.33,0.30,0.29;MQM=59;SAP=5;ABP=87	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:intron19/46:c.1905-9del::,KIF1B:ENST00000377081:intron_variant:MODIFIER:intron20/47:c.2043-9del::,KIF1B:ENST00000377083:intron_variant:MODIFIER:intron19/20:c.1905-9del::,KIF1B:ENST00000377086:intron_variant:MODIFIER:intron21/48:c.2043-9del::,KIF1B:ENST00000377093:intron_variant:MODIFIER:intron19/20:c.1905-9del::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];			(T)n (Simple_repeat)	rs199617049		0.4250	0,.	0.4308,0.4320,0.4215,0.4277,0.4367	-0.0240										0.15264203718760555	0.1650713054280393	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RNU6-37P(inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10366487	10366487	T	G	wt	wt	het		QUAL=2585;DP=248,227,230;AF=0.00,0.00,0.45;MQM=60;SAP=4;ABP=7	KIF1B	intron,3'UTR	KIF1B:ENST00000263934:intron_variant:MODIFIER:intron20/46:c.1977+9183T>G::,KIF1B:ENST00000377081:intron_variant:MODIFIER:intron21/47:c.2115+9183T>G::,KIF1B:ENST00000377083:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::,KIF1B:ENST00000377086:intron_variant:MODIFIER:intron22/48:c.2115+9183T>G::,KIF1B:ENST00000377093:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1782T>G::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs8019	0.3838	0.3972	2475,.		0.6540			0.00,0.09				gain/acceptor/10366486-10366487/Medium/2.203688			0.005542870489685923	0.9466470501056532	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P(inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10366692	10366692	C	G	wt	wt	het		QUAL=2877;DP=288,280,252;AF=0.00,0.00,0.47;MQM=60;SAP=86;ABP=4	KIF1B,RN7SL731P	intron,3'UTR,non_coding_transcript_exon	KIF1B:ENST00000263934:intron_variant:MODIFIER:intron20/46:c.1977+9388C>G::,KIF1B:ENST00000377081:intron_variant:MODIFIER:intron21/47:c.2115+9388C>G::,KIF1B:ENST00000377083:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,KIF1B:ENST00000377086:intron_variant:MODIFIER:intron22/48:c.2115+9388C>G::,KIF1B:ENST00000377093:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1987C>G::,RN7SL731P:ENST00000584329:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.170C>G::		regulatory_region_variant:enhancer	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];			7SLRNA (srpRNA)	rs4623	0.3343	0.3429	1850,.		-0.5090			0.00,0.03							-0.08143009183925308	0.9561837759100078	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P(inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10367424	10367424	G	A	wt	wt	het		QUAL=343;DP=114,47,43;AF=0.01,0.00,0.42;MQM=60;SAP=28;ABP=5	KIF1B	intron,3'UTR	KIF1B:ENST00000263934:intron_variant:MODIFIER:intron20/46:c.1977+10120G>A::,KIF1B:ENST00000377081:intron_variant:MODIFIER:intron21/47:c.2115+10120G>A::,KIF1B:ENST00000377086:intron_variant:MODIFIER:intron22/48:c.2115+10120G>A::,KIF1B:ENST00000377093:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2719G>A::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];			AluSx (SINE/Alu)	rs2004034	0.2316	0.2406	1052,.		-0.1060			0.00,0.11							0.00098748475564772	0.9466165278823861	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P(inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10367591	10367591	T	C	wt	wt	het		QUAL=1134;DP=189,99,87;AF=0.00,0.01,0.59;MQM=60;SAP=115;ABP=8	KIF1B	intron,3'UTR	KIF1B:ENST00000263934:intron_variant:MODIFIER:intron20/46:c.1977+10287T>C::,KIF1B:ENST00000377081:intron_variant:MODIFIER:intron21/47:c.2115+10287T>C::,KIF1B:ENST00000377086:intron_variant:MODIFIER:intron22/48:c.2115+10287T>C::,KIF1B:ENST00000377093:3_prime_UTR_variant:MODIFIER:exon21/21:c.*2886T>C::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];			AluSx (SINE/Alu)	rs1065828	0.3341	0.3429	1865,.		-0.8920			0.00,0.03							0.0033415557894371038	0.9466413231008122	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10), RN7SL731P(inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	10384176	10384176	-	TTGAAA	het	het	het	off-target	QUAL=5259;DP=226,186,143;AF=0.45,0.42,0.45;MQM=60;SAP=445;ABP=18	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:intron23/46:c.2399+57_2399+58insTGAAAT::,KIF1B:ENST00000377081:intron_variant:MODIFIER:intron24/47:c.2537+57_2537+58insTGAAAT::,KIF1B:ENST00000377086:intron_variant:MODIFIER:intron25/48:c.2537+57_2537+58insTGAAAT::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs3831405	0.2326	0.2390	973,.												0.10595904865743933	0.5623393693339506	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10394536	10394536	C	G	het	het	het	off-target	QUAL=8177;DP=248,219,152;AF=0.53,0.53,0.48;MQM=60;SAP=433;ABP=4	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:intron25/46:c.2787-42C>G::,KIF1B:ENST00000377081:intron_variant:MODIFIER:intron26/47:c.2925-42C>G::,KIF1B:ENST00000377086:intron_variant:MODIFIER:intron27/48:c.2925-42C>G::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs2276100	0.3339	0.3308	1727,.	0.3230,0.3842,0.3667,0.3197,0.2621	-0.0570			0.09,0.23							-0.18908294200736026	0.06416318449253484	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10397080	10397080	A	G	wt	het	wt	off-target	QUAL=1131;DP=203,101,79;AF=0.00,0.47,0.00;MQM=60;SAP=47;ABP=4	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:intron27/46:c.2992-52A>G::,KIF1B:ENST00000377081:intron_variant:MODIFIER:intron28/47:c.3130-52A>G::,KIF1B:ENST00000377086:intron_variant:MODIFIER:intron29/48:c.3130-52A>G::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs71643087	0.0112	0.0281	17,.		0.0100			0.01,0.20							-0.003364336308724969	0.36061245847674084	6	381	0 / 0					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10420937	10420937	C	T	het	het	het	off-target	QUAL=11846;DP=259,371,298;AF=0.51,0.49,0.51;MQM=59;SAP=364;ABP=3	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:intron36/46:c.3918-50C>T::,KIF1B:ENST00000377081:intron_variant:MODIFIER:intron37/47:c.4056-50C>T::,KIF1B:ENST00000377086:intron_variant:MODIFIER:intron38/48:c.4056-50C>T::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs3748579	0.3341	0.3302	1713,.	0.3225,0.3839,0.3664,0.3196,0.2625	-0.4610			0.01,0.18							-0.044377843056892845	0.1021683348381469	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10425118	10425118	T	-	het	het	het	off-target	QUAL=2916;DP=98,113,92;AF=0.47,0.52,0.45;MQM=60;SAP=157;ABP=3	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:intron39/46:c.4229-33del::,KIF1B:ENST00000377081:intron_variant:MODIFIER:intron40/47:c.4367-33del::,KIF1B:ENST00000377086:intron_variant:MODIFIER:intron41/48:c.4367-33del::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs34161257	0.5240	0.5252	4371,.	0.6622,0.4695,0.3722,0.4743,0.4639	0.5110										-0.10553682057134808	0.16668925335436793	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10431158	10431158	T	C	het	het	het	off-target	QUAL=7040;DP=219,224,156;AF=0.45,0.53,0.47;MQM=60;SAP=385;ABP=4	KIF1B	intron	KIF1B:ENST00000263934:intron_variant:MODIFIER:intron42/46:c.4687-41T>C::,KIF1B:ENST00000377081:intron_variant:MODIFIER:intron43/47:c.4825-41T>C::,KIF1B:ENST00000377086:intron_variant:MODIFIER:intron44/48:c.4825-41T>C::			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];				rs17411502	0.2490	0.2841	1126,.	0.1495,0.3490,0.2841,0.2958,0.2375	-0.7390			0.03,0.17							-0.030933803233235954	0.0985025182706142	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10435324	10435324	C	A	het	het	het		QUAL=7167;DP=295,147,115;AF=0.45,0.52,0.57;MQM=60;SAP=3;ABP=3	KIF1B	synonymous	KIF1B:ENST00000263934:synonymous_variant:LOW:exon46/47:c.5163C>A:p.Thr1721=:PF00169 [PH domain],KIF1B:ENST00000377081:synonymous_variant:LOW:exon47/48:c.5301C>A:p.Thr1767=:PF00169 [PH domain],KIF1B:ENST00000377086:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:PF00169 [PH domain]			605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	129401 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2,not specified];			rs11121552	0.2316	0.2795	1058,.	0.0874,0.3464,0.2848,0.2956,0.2374	-0.4200			0.27,0.97							-0.16047153207691675	0.0888271539097315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10436892	10436892	-	AC	het	wt	het		QUAL=4747;DP=131,126,112;AF=0.81,0.52,0.31;MQM=59;SAP=32;ABP=208	KIF1B	3'UTR,intron	KIF1B:ENST00000263934:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279_*280dup::,KIF1B:ENST00000377081:intron_variant:MODIFIER:intron47/47:c.5409-1473_5409-1472dup::,KIF1B:ENST00000377086:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::		regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	291586 [uncertain significance DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];		(AC)n (Simple_repeat)	rs146112447		0.0594	37,.												-0.0038247087275311425	0.857081288904515	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10436924	10436924	C	T	het	het	wt		QUAL=4747;DP=131,126,112;AF=0.81,0.52,0.31;MQM=59;SAP=15;ABP=8	KIF1B	3'UTR,intron	KIF1B:ENST00000263934:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279C>T::,KIF1B:ENST00000377081:intron_variant:MODIFIER:intron47/47:c.5409-1473C>T::,KIF1B:ENST00000377086:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::		regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	291594 [likely benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];		(AC)n (Simple_repeat)	rs78490707	0.0403	0.0080	11,.		-3.5950			0.04,0.22							-0.0033487288476583676	0.8570863582105743	0	5	0 / 0					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10438006	10438006	A	T	het	wt	het		QUAL=1323;DP=82,72,54;AF=0.45,0.00,0.48;MQM=59;SAP=92;ABP=4	KIF1B	intron,3'UTR	KIF1B:ENST00000377081:intron_variant:MODIFIER:intron47/47:c.5409-391A>T::,KIF1B:ENST00000377086:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::		regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	291610 [likely benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];		AluSg (SINE/Alu)	rs2847347	0.0182	0.0370	20,.		0.2110			0.16,0.23							-0.003198924327326316	0.8570162037995196	1	26	0 / 0					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10438687	10438687	C	T	het	het	het		QUAL=12136;DP=254,354,281;AF=0.56,0.51,0.51;MQM=60;SAP=3;ABP=7	KIF1B	3'UTR	KIF1B:ENST00000377081:3_prime_UTR_variant:MODIFIER:exon48/48:c.*227C>T::,KIF1B:ENST00000377086:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::		regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	291618 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];			rs1536262	0.5465	0.5500	4954,.		-1.2450			0.03,0.16							0.0004539445182089348	0.9366615153836789	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10438892	10438892	G	A	het	het	het		QUAL=8836;DP=282,193,160;AF=0.54,0.52,0.57;MQM=60;SAP=75;ABP=11	KIF1B	3'UTR	KIF1B:ENST00000377081:3_prime_UTR_variant:MODIFIER:exon48/48:c.*432G>A::,KIF1B:ENST00000377086:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::		regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	291619 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];			rs1002076	0.3337	0.3304	1723,.		0.4730			0.09,0.20							-8.402343904262031	0.9366562030926944	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10440556	10440556	A	G	het	het	het		QUAL=8812;DP=324,225,182;AF=0.49,0.48,0.49;MQM=51;SAP=14;ABP=4	KIF1B	3'UTR	KIF1B:ENST00000377081:3_prime_UTR_variant:MODIFIER:exon48/48:c.*2096A>G::,KIF1B:ENST00000377086:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::		regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	291652 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];		AluSx (SINE/Alu)	rs1138791	0.3488	0.3605	2039,.		-1.5600			0.00,0.08							-0.0029494961112069397	0.9366207498036606	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10441664	10441664	T	C	het	het	het		QUAL=13580;DP=455,349,272;AF=0.53,0.50,0.44;MQM=60;SAP=311;ABP=3	KIF1B	downstream_gene	KIF1B:ENST00000263934:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000377081:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000377086:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter_flanking_region	605995 [GENE=KIF1B PHENOS=Charcot-Marie-Tooth disease,type 2A1,118210,Autosomal dominant/Neuroblastoma,susceptibility to,1,256700,Autosomal dominant,Somatic mutation/Pheochromocytoma,171300,Autosomal dominant];	368794 [benign DISEASE=Pheochromocytoma,Neuroblastoma,Charcot-Marie-Tooth disease, type 2];			rs3748581		0.5293	4497,.		0.2790			0.31,0.74									n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B(inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	11085004	11085004	-	TGTTT	het	hom	het		QUAL=16984;DP=383,272,258;AF=0.49,0.99,0.50;MQM=60;SAP=35;ABP=3	TARDBP,MASP2,RP4-635E18.8	downstream_gene,upstream_gene	TARDBP:ENST00000240185:downstream_gene_variant:MODIFIER::::,TARDBP:ENST00000315091:downstream_gene_variant:MODIFIER::::,MASP2:ENST00000400897:downstream_gene_variant:MODIFIER::::,TARDBP:ENST00000439080:downstream_gene_variant:MODIFIER::::,RP4-635E18.8:ENST00000607145:upstream_gene_variant:MODIFIER::::				291763 [benign DISEASE=Frontotemporal dementia,MASP2 deficiency,Amyotrophic Lateral Sclerosis, Dominant];			rs5772439		0.8767	12057,.												-0.019166757878779195	0.915907931564799	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP(inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2(inh=AR+AD oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11846092	11846092	-	T	hom	hom	hom		QUAL=4416;DP=114,51,37;AF=0.75,0.90,0.89;MQM=59;SAP=250;ABP=0	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4644dup::,C1orf167:ENST00000433342:intron_variant:MODIFIER:intron16/20:c.3639+757dup::			607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292153 [benign DISEASE=Neural tube defects, folate-sensitive];			rs55740775		0.9797	13625,.												-0.00018881280794484374	0.9617908961276704	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11846252	11846252	G	A	hom	het	het		QUAL=14846;DP=330,181,158;AF=1.00,0.54,0.50;MQM=60;SAP=44;ABP=4	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4485C>T::,C1orf167:ENST00000433342:intron_variant:MODIFIER:intron16/20:c.3639+906G>A::		regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292158 [likely benign DISEASE=Neural tube defects, folate-sensitive];		Tigger15a (DNA/TcMar-Tigger)	rs4846048	0.7065	0.6858	7531,.		0.4870			0.00,0.12							-0.001793861240073969	0.9617785972514393	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11846447	11846447	G	A	hom	hom	hom		QUAL=25207;DP=380,216,181;AF=1.00,1.00,1.00;MQM=60;SAP=28;ABP=0	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4290C>T::,C1orf167:ENST00000433342:intron_variant:MODIFIER:intron16/20:c.3640-998G>A::		regulatory_region_variant:CTCF_binding_site	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292160 [benign DISEASE=Neural tube defects, folate-sensitive];			rs4845884		0.9393	13972,.		-0.7990			0.00,0.10							-0.004450493127735969	0.9617582321370611	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11846660	11846663	TTTT	-	hom	hom	hom		QUAL=1828;DP=78,39,31;AF=0.62,0.56,0.42;MQM=57;SAP=35;ABP=0	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*4074_*4077del::,C1orf167:ENST00000433342:intron_variant:MODIFIER:intron16/20:c.3640-770_3640-767del::			607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292164 [likely benign DISEASE=Neural tube defects, folate-sensitive];		AluJr (SINE/Alu)	rs55780505	0.7772	0.5146	3151,.		0.3100										0.004763591802638403	0.961822962758304	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11847334	11847334	-	GAA	hom	het	het		QUAL=9662;DP=228,222,133;AF=0.97,0.41,0.58;MQM=59;SAP=75;ABP=5	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*3400_*3402dup::,C1orf167:ENST00000433342:intron_variant:MODIFIER:intron16/20:c.3640-108_3640-106dup::		regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292171 [likely benign DISEASE=Neural tube defects, folate-sensitive];			rs35134728	0.5701	0.5694	5257,.												0.0018080888276144269	0.9618052089288487	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11847759	11847759	C	T	hom	het	het		QUAL=11899;DP=193,292,241;AF=0.98,0.52,0.50;MQM=59;SAP=44;ABP=3	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*2978G>A::,C1orf167:ENST00000433342:intron_variant:MODIFIER:intron17/20:c.3746-171C>T::		TF_binding_site_variant	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292181 [likely benign DISEASE=Neural tube defects, folate-sensitive];			rs3737966	0.5585	0.5604	5155,.		0.6900			0.30,0.29							-0.06110833380524303	0.9617826350947125	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11848139	11848139	G	A	wt	het	het		QUAL=2672;DP=121,122,85;AF=0.01,0.48,0.55;MQM=60;SAP=3;ABP=3	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*2598C>T::,C1orf167:ENST00000433342:intron_variant:MODIFIER:intron18/20:c.3920+35G>A::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292191 [likely benign DISEASE=Neural tube defects, folate-sensitive];			rs11559040	0.1268	0.1685	357,.	0.0352,0.0850,0.1026,0.1856,0.2669	-0.6770			0.09,0.19							-0.018844111798651926	0.9617815153977097	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11848879	11848879	A	G	hom	hom	hom		QUAL=18803;DP=241,217,151;AF=1.00,1.00,1.00;MQM=60;SAP=10;ABP=0	MTHFR,C1orf167	3'UTR,intron	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376585:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1858T>C::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1858T>C::,C1orf167:ENST00000433342:intron_variant:MODIFIER:intron20/20:c.4245+76A>G::		regulatory_region_variant:promoter	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292203 [benign DISEASE=Neural tube defects, folate-sensitive];			rs2077360	0.9305	0.9366	13907,.		-0.5590			0.01,0.11							-0.07211797277085055	0.9618197143209495	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11849447	11849447	A	G	hom	hom	hom		QUAL=17657;DP=146,226,188;AF=1.00,1.00,1.00;MQM=59;SAP=9;ABP=0	MTHFR,C1orf167	3'UTR,missense	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376585:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1290T>C::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1290T>C::,C1orf167:ENST00000433342:missense_variant:MODERATE:exon21/21:c.4366A>G:p.Arg1456Gly:			607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292209 [benign DISEASE=Neural tube defects, folate-sensitive];			rs868014	0.9329	0.9874	13971,.	0.7812,0.9875,1.0000,0.9990,0.9997	-4.9500	 , , , ,T(0.24)	 , , , ,B(0.00)	0.02,0.21		0.03					0.10784976448354956	0.9618408441834341	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11850365	11850365	T	G	hom	het	het		QUAL=18805;DP=311,383,349;AF=1.00,0.48,0.49;MQM=59;SAP=226;ABP=4	MTHFR	3'UTR	MTHFR:ENST00000376583:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376585:3_prime_UTR_variant:MODIFIER:exon13/13:c.*372A>C::,MTHFR:ENST00000376590:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376592:3_prime_UTR_variant:MODIFIER:exon11/11:c.*372A>C::			607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	292223 [likely benign DISEASE=Neural tube defects, folate-sensitive];			rs4846049		0.6369	6490,.		-0.6840			0.05,0.19							-0.0011164201087201589	0.9617904607840739	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11851003	11851003	G	C	wt	het	het	off-target	QUAL=3861;DP=207,180,166;AF=0.00,0.43,0.48;MQM=60;SAP=44;ABP=9	MTHFR	intron	MTHFR:ENST00000376583:intron_variant:MODIFIER:intron11/11:c.1876-48C>G::,MTHFR:ENST00000376585:intron_variant:MODIFIER:intron12/12:c.1876-48C>G::,MTHFR:ENST00000376590:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::,MTHFR:ENST00000376592:intron_variant:MODIFIER:intron10/10:c.1753-48C>G::		TF_binding_site_variant	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];				rs3818762	0.2475	0.2600	880,.	0.1340,0.1420,0.2153,0.2748,0.4137	-1.1340			0.00,0.02							-0.11069385426558398	0.9177499052892847	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11852300	11852300	C	T	wt	het	het	off-target	QUAL=4633;DP=171,209,197;AF=0.01,0.48,0.47;MQM=60;SAP=13;ABP=5	MTHFR	intron	MTHFR:ENST00000376583:intron_variant:MODIFIER:intron10/11:c.1755+35G>A::,MTHFR:ENST00000376585:intron_variant:MODIFIER:intron11/12:c.1755+35G>A::,MTHFR:ENST00000376590:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::,MTHFR:ENST00000376592:intron_variant:MODIFIER:intron9/10:c.1632+35G>A::			607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];				rs1476413	0.2512	0.2614	890,.	0.1509,0.1389,0.2267,0.2731,0.4203	-1.1060			0.07,0.25							-0.7169694303724746	0.8160656087946528	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11854457	11854457	G	A	hom	hom	hom		QUAL=18479;DP=119,264,204;AF=1.00,1.00,1.00;MQM=60;SAP=65;ABP=0	MTHFR	synonymous	MTHFR:ENST00000376583:synonymous_variant:LOW:exon8/12:c.1428C>T:p.Phe476=:,MTHFR:ENST00000376585:synonymous_variant:LOW:exon9/13:c.1428C>T:p.Phe476=:,MTHFR:ENST00000376590:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:ENST00000376592:synonymous_variant:LOW:exon7/11:c.1305C>T:p.Phe435=:			607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	167306 [benign DISEASE=Neural tube defects, folate-sensitive,not specified];			rs4846051	0.9030	0.9748	13266,.	0.6780,0.9819,0.9991,0.9983,0.9993	0.6310			0.47,0.83							-0.49865708375400813	0.6090054769297943	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11854476	11854476	T	G	wt	het	het		QUAL=7156;DP=166,287,228;AF=0.01,0.54,0.54;MQM=60;SAP=6;ABP=10	MTHFR	missense	MTHFR:ENST00000376583:missense_variant:MODERATE:exon8/12:c.1409A>C:p.Glu470Ala:,MTHFR:ENST00000376585:missense_variant:MODERATE:exon9/13:c.1409A>C:p.Glu470Ala:,MTHFR:ENST00000376590:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000376592:missense_variant:MODERATE:exon7/11:c.1286A>C:p.Glu429Ala:		regulatory_region_variant:promoter_flanking_region	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];	3521 [likely benign(replaced by megSAP based on classifications:3x1,1x2,1x3) DISEASE=Schizophrenia, susceptibility to,Gastrointestinal stroma tumor,MTHFR deficiency, thermolabile type,Neural tube defects, folate-sensitive,not specified,not provided];	CM981315 [CLASS=DFP MUT=ALT PHEN="Neural tube defect increased risk association with" GENE=MTHFR];		rs1801131	0.2494	0.2890	1116,.	0.1582,0.1594,0.2198,0.3186,0.4116	3.7910	T(0.15),T(0.15),T(0.14),T(0.14)	B(0.07),B(0.07),B(0.01),B(0.01)	0.96,0.96		0.20					-0.20947478355411708	0.6926272788450626	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167(inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11854755	11854755	G	A	hom	het	het	off-target	QUAL=3013;DP=70,54,57;AF=1.00,0.39,0.46;MQM=59;SAP=192;ABP=8	MTHFR	intron	MTHFR:ENST00000376583:intron_variant:MODIFIER:intron7/11:c.1289+31C>T::,MTHFR:ENST00000376585:intron_variant:MODIFIER:intron8/12:c.1289+31C>T::,MTHFR:ENST00000376590:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::,MTHFR:ENST00000376592:intron_variant:MODIFIER:intron6/10:c.1166+31C>T::		regulatory_region_variant:promoter_flanking_region	607093 [GENE=MTHFR PHENOS=Homocystinuria due to MTHFR deficiency,236250,Autosomal recessive/Neural tube defects,susceptibility to,601634,Autosomal recessive/Schizophrenia,susceptibility to,181500,Autosomal dominant/Thromboembolism,susceptibility to,188050,Autosomal dominant/Vascular disease,susceptibility to];				rs1994798	0.5793	0.6074	5239,.	0.4333,0.7727,0.7596,0.5879,0.4685	-3.8760			0.03,0.15							0.10123218124749973	0.7005338938609648	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR(inh=AR oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	12009955	12009955	C	T	het	het	het		QUAL=6842;DP=122,248,190;AF=0.46,0.49,0.53;MQM=60;SAP=58;ABP=3	PLOD1	synonymous	PLOD1:ENST00000196061:synonymous_variant:LOW:exon3/19:c.294C>T:p.Phe98=:,PLOD1:ENST00000376369:synonymous_variant:LOW:exon4/20:c.435C>T:p.Phe145=:			153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];	255803 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified,Cardiovascular phenotype,not provided];			rs7529452	0.2678	0.3295	1533,.	0.0589,0.3522,0.3748,0.3160,0.4236	0.9490			0.69,0.83							-0.3139532737134739	0.17396281815084347	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1(inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12009956	12009956	G	A	wt	wt	het		QUAL=2008;DP=146,243,188;AF=0.00,0.00,0.47;MQM=60;SAP=3;ABP=4	PLOD1	missense	PLOD1:ENST00000196061:missense_variant:MODERATE:exon3/19:c.295G>A:p.Ala99Thr:,PLOD1:ENST00000376369:missense_variant:MODERATE:exon4/20:c.436G>A:p.Ala146Thr:			153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];	196247 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified,Cardiovascular phenotype,not provided];	CM068658 [CLASS=DP MUT=ALT PHEN="Bone mineral density association with" GENE=PLOD1];		rs7551175	0.2995	0.2590	1527,.	0.5503,0.0894,0.2527,0.1526,0.2126	1.4500	T(1.00),T(1.00)	B(0.00),B(0.00)	0.03,0.33		0.15					-0.12745181157318447	0.1796211213421261	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1(inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12016957	12016957	T	G	wt	wt	het	off-target	QUAL=3761;DP=108,392,311;AF=0.00,0.00,0.50;MQM=60;SAP=69;ABP=3	PLOD1	intron	PLOD1:ENST00000196061:intron_variant:MODIFIER:intron6/18:c.644-17T>G::,PLOD1:ENST00000376369:intron_variant:MODIFIER:intron7/19:c.785-17T>G::			153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];	384719 [benign DISEASE=not specified];			rs41307745	0.0769	0.0679	50,.	0.0104,0.0250,0.1423,0.0613,0.1356	3.2240			0.64,0.22			10.55>8.84				-0.7659329680714002	0.521573348725274	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1(inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12024235	12024235	C	T	het	het	het		QUAL=1152;DP=18,53,36;AF=0.56,0.53,0.39;MQM=60;SAP=3;ABP=3	PLOD1	synonymous	PLOD1:ENST00000196061:synonymous_variant:LOW:exon12/19:c.1206C>T:p.Asn402=:,PLOD1:ENST00000376369:synonymous_variant:LOW:exon13/20:c.1347C>T:p.Asn449=:			153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];	255799 [benign DISEASE=Ehlers-Danlos syndrome, hydroxylysine-deficient,not specified,Cardiovascular phenotype,not provided];			rs1130529	0.3484	0.3609	2053,.	0.2929,0.3668,0.3896,0.3275,0.4443	-1.0670			0.12,0.58							-0.24741792808697916	0.3035848236305599	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1(inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12027204	12027204	C	T	het	het	hom	off-target	QUAL=9497;DP=42,211,205;AF=0.45,0.52,1.00;MQM=59;SAP=126;ABP=3	PLOD1	intron	PLOD1:ENST00000196061:intron_variant:MODIFIER:intron16/18:c.1755+56C>T::,PLOD1:ENST00000376369:intron_variant:MODIFIER:intron17/19:c.1896+56C>T::		regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];				rs2273293	0.5639	0.5222	4329,.		-3.7710			0.01,0.05							-0.044688060012847565	0.29837557438799633	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1(inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12033113	12033113	A	G	het	het	hom	off-target	QUAL=11228;DP=132,264,209;AF=0.51,0.48,1.00;MQM=60;SAP=387;ABP=3	PLOD1	intron	PLOD1:ENST00000196061:intron_variant:MODIFIER:intron18/18:c.2028+59A>G::,PLOD1:ENST00000376369:intron_variant:MODIFIER:intron19/19:c.2169+59A>G::		regulatory_region_variant:promoter_flanking_region	153454 [GENE=PLOD1 PHENOS=Ehlers-Danlos syndrome,kyphoscoliotic type,1,225400,Autosomal recessive];				rs3737961	0.6498	0.5826	5517,.		-0.4870			0.00,0.07							0.32965439862504636	0.15244005759693122	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1(inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	12040203	12040203	A	G	het	het	hom	off-target	QUAL=901;DP=25,24,20;AF=0.44,0.46,1.00;MQM=60;SAP=85;ABP=4	PLOD1,MFN2	downstream_gene,upstream_gene	PLOD1:ENST00000196061:downstream_gene_variant:MODIFIER::::,MFN2:ENST00000235329:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000444836:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter					rs2236053		0.5216	4305,.		-0.9190			0.00,0.13				loss/acceptor/12040203-12040204/Medium/10.214891					n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1(inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2(inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12040324	12040324	A	G	het	het	hom		QUAL=4120;DP=30,123,101;AF=0.47,0.36,1.00;MQM=60;SAP=111;ABP=22	MFN2	5'UTR	MFN2:ENST00000444836:5_prime_UTR_variant:MODIFIER:exon1/18:c.-222A>G::		regulatory_region_variant:promoter	608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];	292362 [benign DISEASE=Hereditary motor and sensory neuropathy,Ehlers-Danlos syndrome, hydroxylysine-deficient,Charcot-Marie-Tooth disease, type 2];			rs2236054		0.5264	4410,.		-0.9110			0.00,0.09							-0.06332071780502378	0.17296825380942227	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1(inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2(inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12040479	12040479	T	C	het	het	hom		QUAL=5101;DP=51,128,113;AF=0.45,0.43,1.00;MQM=60;SAP=138;ABP=9	MFN2	5'UTR	MFN2:ENST00000235329:5_prime_UTR_variant:MODIFIER:exon1/19:c.-212T>C::,MFN2:ENST00000444836:5_prime_UTR_variant:MODIFIER:exon1/18:c.-67T>C::		regulatory_region_variant:promoter	608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];	292368 [benign DISEASE=Hereditary motor and sensory neuropathy,Ehlers-Danlos syndrome, hydroxylysine-deficient,Charcot-Marie-Tooth disease, type 2];			rs2180183		0.5520	4937,.		-0.2970			0.00,0.05							0.13347076518014317	0.20387894087768837	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1(inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2(inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12062205	12062205	A	G	hom	hom	hom	off-target	QUAL=14516;DP=175,190,138;AF=0.99,0.99,0.99;MQM=59;SAP=1060;ABP=0	MFN2	intron	MFN2:ENST00000235329:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000444836:intron_variant:MODIFIER:intron10/17:c.1160+45A>G::		regulatory_region_variant:CTCF_binding_site	608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];				rs2236057	0.6579	0.6615	6882,.	0.6479,0.5317,0.6765,0.6679,0.7034	-2.0590			0.01,0.11							-0.03786277813900628	0.45073190626103143	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2(inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12071680	12071680	A	G	hom	hom	hom		QUAL=29203;DP=253,418,322;AF=0.99,1.00,0.99;MQM=60;SAP=133;ABP=0	MFN2	3'UTR	MFN2:ENST00000235329:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000444836:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::			608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];	292381 [benign DISEASE=Hereditary motor and sensory neuropathy,Charcot-Marie-Tooth disease, type 2];			rs1042842	0.7324	0.7195	8238,.		-0.8580			0.04,0.13							0.008595045347288709	0.9417731290109154	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2(inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12072518	12072518	G	C	hom	hom	hom		QUAL=12743;DP=106,172,143;AF=0.99,1.00,1.00;MQM=60;SAP=74;ABP=0	MFN2	3'UTR	MFN2:ENST00000235329:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000444836:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::			608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];	292393 [benign DISEASE=Hereditary motor and sensory neuropathy,Charcot-Marie-Tooth disease, type 2];			rs3088064	0.5441	0.5709	5189,.		0.4850			0.22,0.22							0.0033577907620839275	0.9417132264224689	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2(inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12072534	12072534	C	T	wt	wt	het		QUAL=1666;DP=102,189,145;AF=0.00,0.00,0.50;MQM=60;SAP=4;ABP=3	MFN2	3'UTR	MFN2:ENST00000235329:3_prime_UTR_variant:MODIFIER:exon19/19:c.*912C>T::,MFN2:ENST00000444836:3_prime_UTR_variant:MODIFIER:exon18/18:c.*912C>T::			608507 [GENE=MFN2 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant];	292394 [likely benign DISEASE=Hereditary motor and sensory neuropathy,Charcot-Marie-Tooth disease, type 2];			rs14305	0.0843	0.0541	51,.		0.1270			0.12,0.31							-0.01344024025426333	0.9415207038684063	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2(inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	16370428	16370432	GGGGG	-	wt	hom	wt	off-target	QUAL=48;DP=102,4,145;AF=0.00,0.75,0.50;MQM=60;SAP=9;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375679:intron_variant:MODIFIER:intron1/19:c.-8+61_-8+65del::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs140434107	0.9447	0.5123	2076,.		1.3540										-0.17326229817295108	0.1523873522873569	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16371067	16371067	G	T	het	hom	n/a		QUAL=234;DP=4,5,1;AF=0.75,1.00,1.00;MQM=60;SAP=3;ABP=5	CLCNKB	missense	CLCNKB:ENST00000375679:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:		regulatory_region_variant:TF_binding_site	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447107 [benign DISEASE=not specified,not provided];			rs2015352		0.6267	4826,.	0.2881,0.7293,0.6328,0.6333,0.6878	-0.4670	D(0.01)	B(0.16)	0.14,0.92		0.30					-0.19372887354393437	0.14630743715712255	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16372003	16372003	G	C	het	hom	het	off-target	QUAL=6416;DP=54,148,129;AF=0.41,1.00,0.48;MQM=60;SAP=355;ABP=5	CLCNKB	intron	CLCNKB:ENST00000375679:intron_variant:MODIFIER:intron2/19:c.101-50G>C::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs6604910	0.5665	0.6357	4863,.	0.2698,0.7354,0.6801,0.6380,0.7118	0.6820			0.01,0.14							0.03739102748341761	0.042660749211455296	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16372971	16372971	G	A	hom	hom	hom	off-target	QUAL=12404;DP=81,182,142;AF=1.00,1.00,1.00;MQM=59;SAP=444;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375679:intron_variant:MODIFIER:intron3/19:c.230-59G>A::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs2014841		0.6933	8183,.		-0.2720			0.02,0.13							0.012875479277191055	0.18640236481710706	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16373124	16373124	A	G	hom	hom	hom		QUAL=23051;DP=179,312,248;AF=0.98,1.00,1.00;MQM=59;SAP=4;ABP=0	CLCNKB	synonymous	CLCNKB:ENST00000375679:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel]			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447104 [benign DISEASE=not specified,not provided];			rs5257	0.7404	0.8121	8159,.	0.3791,0.8994,0.9891,0.8093,0.8739	-4.7220			0.03,0.24				loss/acceptor/16373124-16373125/Medium/12.831041			0.017743452433773663	0.19102271289841033	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16373200	16373202	CTT	-	hom	hom	het	off-target	QUAL=9995;DP=121,222,148;AF=0.99,1.00,0.50;MQM=59;SAP=366;ABP=3	CLCNKB	intron	CLCNKB:ENST00000375679:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs35820664	0.7234	0.7861	7533,.	0.3540,0.8883,0.9891,0.7803,0.8442	0.5420										0.027665967713535276	0.19029903854644908	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16374533	16374533	G	C	hom	hom	hom		QUAL=383;DP=5,3,5;AF=1.00,1.00,1.00;MQM=60;SAP=23;ABP=0	CLCNKB	synonymous	CLCNKB:ENST00000375679:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel]		regulatory_region_variant:promoter	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447105 [benign DISEASE=not specified,not provided];			rs2014562		0.9317	12637,.	0.7589,0.9575,0.9997,0.9439,0.9278	-0.3820			0.06,0.95							0.08097129136012927	0.6193928145994354	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16374994	16374994	C	T	hom	hom	hom		QUAL=17810;DP=154,245,203;AF=0.99,1.00,1.00;MQM=46;SAP=4;ABP=0	CLCNKB	splice_region&intron	CLCNKB:ENST00000375679:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	381050 [benign/likely benign DISEASE=not specified,not provided];			rs34666902,rs1889788	0.7386	0.8104	8128,.	0.3760,0.8986,0.9890,0.8075,0.8732	-0.3170			0.02,0.22			4.28>4.16		0.000/0.000		-0.17526896872559913	0.4113628404012854	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16375063	16375063	C	G	hom	hom	hom		QUAL=16997;DP=185,216,173;AF=0.99,1.00,1.00;MQM=52;SAP=218;ABP=0	CLCNKB	missense	CLCNKB:ENST00000375679:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel]		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	504916 [benign DISEASE=not specified];			rs45612832,rs1889789		0.9069	11137,.	0.5589,0.9388,0.9997,0.9259,0.9256	-0.0390	T(0.79)	B(0.00)	0.06,0.42		0.22					0.2561702607250212	0.22735276082573383	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16375064	16375064	A	C	hom	hom	hom		QUAL=16997;DP=185,216,173;AF=0.99,1.00,1.00;MQM=52;SAP=218;ABP=0	CLCNKB	synonymous	CLCNKB:ENST00000375679:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel]		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	504915 [benign DISEASE=not specified];			rs45575235,rs1889790		0.9069	11137,.	0.5589,0.9388,0.9997,0.9258,0.9256	-2.2040			0.07,0.28							0.023704270231715275	0.21895199928985498	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16375210	16375210	G	A	het	hom	wt	off-target	QUAL=4190;DP=97,100,103;AF=0.48,0.99,0.00;MQM=60;SAP=11;ABP=3	CLCNKB	intron	CLCNKB:ENST00000375679:intron_variant:MODIFIER:intron7/19:c.655+133G>A::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs9633514	0.3570	0.2951	1647,.		-0.2940			0.09,0.19									n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16375354	16375354	C	T	hom	hom	hom		QUAL=18577;DP=165,236,202;AF=1.00,1.00,1.00;MQM=59;SAP=30;ABP=0	CLCNKB	5'UTR,intron	CLCNKB:ENST00000375667:5_prime_UTR_variant:MODIFIER:exon1/13:c.-113C>T::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:intron7/19:c.656-261C>T::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];			MIR (SINE/MIR)	rs9442227	0.7274	0.6835	7971,.		-0.1220			0.08,0.21							0.002429445508006484	0.231391254077955	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376191	16376191	C	T	hom	hom	hom		QUAL=25479;DP=182,405,313;AF=0.99,1.00,1.00;MQM=44;SAP=280;ABP=0	CLCNKB	missense	CLCNKB:ENST00000375667:missense_variant:MODERATE:exon2/13:c.353C>T:p.Ala118Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel]			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447108 [benign DISEASE=not specified,not provided];			rs34188929,rs7367494	0.8299	0.9249	11278,.	0.5573,0.9597,0.9988,0.9484,0.9335	-0.3350	T(1.00),T(1.00)	B(0.00),B(0.01)	0.02,0.12		0.22					-0.3397281376735613	0.13550798719394802	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376230	16376230	-	T	hom	hom	hom	off-target	QUAL=22542;DP=18,441,341;AF=0.67,0.95,0.95;MQM=51;SAP=18;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:intron2/12:c.359+33_359+34insT::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs59006537		0.9242	10761,.	0.4294,0.9451,0.9983,0.9544,0.9487											0.26397627400149964	0.1426903868213076	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376232	16376232	A	T	hom	hom	hom	off-target	QUAL=22542;DP=18,441,341;AF=0.67,0.95,0.95;MQM=51;SAP=18;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:intron2/12:c.359+35A>T::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:intron9/19:c.866+35A>T::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs59924562		0.9253	10777,.	0.4491,0.9459,0.9984,0.9547,0.9477	-2.8490			0.01,0.08							0.10036782687420819	0.14352633091855443	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376239	16376239	C	-	hom	hom	hom	off-target	QUAL=24456;DP=79,440,340;AF=1.00,0.99,0.98;MQM=52;SAP=12;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:intron2/12:c.359+47del::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:intron9/19:c.866+47del::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs34589727	0.8301	0.9148	10750,.	0.4231,0.9419,0.9988,0.9470,0.9354	-0.1430										-0.05814138446271372	0.14434010501011982	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376278	16376278	G	A	hom	hom	hom	off-target	QUAL=30453;DP=138,501,364;AF=0.99,1.00,1.00;MQM=57;SAP=39;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:intron2/12:c.360-32G>A::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:intron9/19:c.867-32G>A::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs7365182	0.8279	0.9209	11342,.	0.5528,0.9546,0.9999,0.9463,0.9313	1.2090			0.08,0.18							-0.2906356043409304	0.15458160191419554	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376319	16376319	T	C	hom	hom	hom		QUAL=32761;DP=182,484,361;AF=1.00,1.00,1.00;MQM=59;SAP=175;ABP=0	CLCNKB	synonymous	CLCNKB:ENST00000375667:synonymous_variant:LOW:exon3/13:c.369T>C:p.Cys123=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel]			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	377683 [benign DISEASE=not specified,not provided];			rs7368151	0.8301	0.9168	11434,.	0.5579,0.9485,0.9998,0.9431,0.9271	-4.5300			0.03,0.87							0.2720812718722102	0.08633766854861608	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16376458	16376458	T	C	hom	hom	hom	off-target	QUAL=16879;DP=125,258,183;AF=0.99,1.00,1.00;MQM=60;SAP=194;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:intron3/12:c.461+47T>C::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:intron10/19:c.968+47T>C::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs7368166		0.9131	11013,.	0.5505,0.9457,0.9985,0.9398,0.9198	-4.4690			0.00,0.06							0.09863308500487915	0.08167031262229425	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16378649	16378649	C	G	het	wt	het	off-target	QUAL=483;DP=19,11,19;AF=0.58,0.00,0.68;MQM=60;SAP=39;ABP=8	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:intron7/12:c.902-44C>G::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs2297726	0.1625	0.1727	421,.	0.0715,0.1591,0.2995,0.1706,0.1631	0.0970			0.05,0.21							-0.005420957090796375	0.01451990539202073	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16378739	16378739	G	A	wt	wt	het		QUAL=107;DP=27,16,22;AF=0.00,0.00,0.36;MQM=60;SAP=4;ABP=6	CLCNKB	synonymous	CLCNKB:ENST00000375667:synonymous_variant:LOW:exon8/13:c.948G>A:p.Ala316=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679:synonymous_variant:LOW:exon15/20:c.1455G>A:p.Ala485=:PF00654 [Voltage gated chloride channel]			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	585703 [benign DISEASE=not provided];			rs34652156	0.0302	0.0371	33,.	0.0580,0.0117,0.0000,0.0274,0.0299	-2.6720			0.05,0.21							-0.04138505589925906	0.051930854384640096	11	435	0 / 0					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16380196	16380196	T	C	hom	hom	hom		QUAL=28212;DP=294,369,251;AF=1.00,1.00,1.00;MQM=51;SAP=161;ABP=0	CLCNKB	missense	CLCNKB:ENST00000375667:missense_variant:MODERATE:exon9/13:c.1178T>C:p.Met393Thr:PF00571 [CBS domain],CLCNKB:ENST00000375679:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571 [CBS domain]			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447094 [benign DISEASE=not specified];			rs5253	0.8383	0.9347	12512,.	0.6863,0.9480,0.8076,0.9843,0.9317	-0.9230	T(0.49),T(0.46)	B(0.00),B(0.00)	0.00,0.10		0.28					0.08771286375172266	0.4845576626056707	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16380243	16380243	A	G	hom	hom	het		QUAL=15362;DP=131,311,232;AF=1.00,0.99,0.42;MQM=48;SAP=8;ABP=15	CLCNKB	missense	CLCNKB:ENST00000375667:missense_variant:MODERATE:exon9/13:c.1225A>G:p.Lys409Glu:PF00571 [CBS domain],CLCNKB:ENST00000375679:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain]			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447096 [benign DISEASE=not specified,not provided];	CM1514575 [CLASS=DM? MUT=ALT PHEN="Migraine without aura" GENE=CLCNKB];		rs2275166	0.7017	0.7153	8082,.	0.7975,0.5184,0.7947,0.6591,0.5830	0.8530	T(1.00),T(1.00)	B(0.00),B(0.00)	0.01,0.19		0.16					0.13044035994495318	0.4867827779829608	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16380252	16380252	C	T	hom	hom	het		QUAL=14358;DP=122,302,218;AF=1.00,1.00,0.43;MQM=48;SAP=16;ABP=11	CLCNKB	synonymous	CLCNKB:ENST00000375667:synonymous_variant:LOW:exon9/13:c.1234C>T:p.Leu412=:PF00571 [CBS domain],CLCNKB:ENST00000375679:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571 [CBS domain]			602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	447097 [benign DISEASE=not specified,not provided];			rs2275167		0.6412	6486,.	0.5768,0.4929,0.7894,0.6443,0.5281	0.5590			0.14,0.85				loss/acceptor/16380251-16380252/Medium/4.504692&gain/acceptor/16380252-16380253/Medium/1.970012			-0.06965678485709766	0.47636829650563145	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16382877	16382877	A	G	hom	hom	hom	off-target	QUAL=11602;DP=50,203,147;AF=1.00,1.00,0.99;MQM=59;SAP=31;ABP=0	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:intron11/12:c.1420-40A>G::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::		regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs7517792		0.7963	8798,.	0.7061,0.8840,0.8077,0.7871,0.8423	-2.5310			0.01,0.13				loss/donor/16382876-16382877/Medium/1.469535			0.40365061313713463	0.05805516069051256	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383329	16383329	-	C	wt	hom	het	off-target	QUAL=125;DP=4,9,26;AF=1.00,0.89,0.27;MQM=46;SAP=16;ABP=19	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:intron12/12:c.1507-29dup::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:intron19/19:c.2017-29dup::		regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs138507185		0.6262	5321,.												-0.07383795241267652	0.7190007337903916	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383336	16383336	G	C	hom	hom	het	off-target	QUAL=125;DP=4,9,26;AF=1.00,0.89,0.27;MQM=39;SAP=16;ABP=51	CLCNKB	intron	CLCNKB:ENST00000375667:intron_variant:MODIFIER:intron12/12:c.1507-28G>C::,CLCNKB:ENST00000375679:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::		regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs12746138		0.7085	6009,.	0.4283,0.8343,0.7670,0.6997,0.7947	-1.1840			0.00,0.06							0.06252566532292284	0.6767679115782504	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383402	16383402	C	T	het	wt	wt		QUAL=694;DP=259,143,140;AF=0.27,0.07,0.00;MQM=34;SAP=174;ABP=125	CLCNKB	synonymous	CLCNKB:ENST00000375667:synonymous_variant:LOW:exon13/13:c.1545C>T:p.Ala515=:,CLCNKB:ENST00000375679:synonymous_variant:LOW:exon20/20:c.2055C>T:p.Ala685=:		regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs6698427		0.0880	0,.	0.0128,0.0033,0.0132,0.0013,0.0025	0.3830			0.26,0.96							0.0486496746802104	0.8798711235378067	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383448	16383448	A	C	het	hom	hom		QUAL=15892;DP=223,289,241;AF=0.70,0.89,1.00;MQM=40;SAP=916;ABP=80	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*37A>C::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::		regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs10803415	0.9010	0.9041	5812,.	0.8429,0.9248,0.6951,0.9399,0.8839	-1.8510			0.00,0.05							-0.03918595505891663	0.8779220904011754	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383547	16383547	T	C	wt	het	wt		QUAL=531;DP=233,597,398;AF=0.05,0.19,0.00;MQM=31;SAP=272;ABP=514	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*136T>C::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*136T>C::		regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057839		0.2174	4,.		0.0660			0.00,0.06							0.012523908727819957	0.8790727825217884	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383574	16383574	A	T	het	het	wt		QUAL=887;DP=245,617,380;AF=0.13,0.20,0.00;MQM=32;SAP=343;ABP=759	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*163A>T::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*163A>T::		regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057841		0.2479	0,.		0.4380			0.07,0.16							-0.009601407176591739	0.8785815803116241	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383581	16383581	G	T	het	het	het		QUAL=19836;DP=246,619,382;AF=0.84,0.80,0.52;MQM=37;SAP=80;ABP=524	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*170G>T::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::		regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057844		0.4996	1874,.		-1.3730			0.03,0.14							0.04890353061614255	0.8798767173481423	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383605	16383605	A	G	het	het	het		QUAL=19759;DP=198,648,402;AF=0.74,0.77,0.53;MQM=37;SAP=3;ABP=377	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*194A>G::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::		regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057845		0.4935	1687,.		-0.5960			0.01,0.17							-0.009343123520846822	0.8785873243509764	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383668	16383668	T	G	hom	hom	hom		QUAL=32690;DP=170,659,360;AF=0.99,1.00,1.00;MQM=41;SAP=396;ABP=0	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*257T>G::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::		regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs6660218		1.0000	15695,.	1.0000,1.0000,0.9998,0.9999,1.0000	0.1210			0.00,0.08							-0.044428179693126804	0.9765403413955362	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383682	16383682	G	C	het	het	wt		QUAL=4389;DP=219,649,322;AF=0.19,0.35,0.00;MQM=41;SAP=35;ABP=265	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*271G>C::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*271G>C::		regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];	402540 [benign DISEASE=not specified];			rs1057854		0.3303	50,.	0.4019,0.2177,0.4238,0.3039,0.2888	-3.2740			0.01,0.12							-0.03123450822848383	0.9754384689358969	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383742	16383742	C	G	het	het	hom		QUAL=18344;DP=347,516,224;AF=0.55,0.53,1.00;MQM=57;SAP=748;ABP=13	CLCNKB	3'UTR	CLCNKB:ENST00000375667:3_prime_UTR_variant:MODIFIER:exon13/13:c.*331C>G::,CLCNKB:ENST00000375679:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::		regulatory_region_variant:promoter_flanking_region	602023 [GENE=CLCNKB PHENOS=Bartter syndrome,type 3,607364,Autosomal recessive/Bartter syndrome,type 4b,digenic,613090,Digenic recessive];				rs1057857		0.6415	4036,.	0.5897,0.6972,0.4932,0.6536,0.6177	-0.3020			0.04,0.20							-0.06893949424742891	0.9738168637613704	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16383854	16383854	A	G	het	het	wt	off-target	QUAL=616;DP=104,110,56;AF=0.36,0.17,0.00;MQM=38;SAP=124;ABP=108	FAM131C,CLCNKB	downstream_gene	FAM131C:ENST00000375662:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375679:downstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter_flanking_region					rs749928769		0.0230	1,.		-0.5780			0.00,0.11									1	19	0 / 0					CLCNKB(inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C(inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	17312743	17312743	C	T	het	het	hom		QUAL=709;DP=17,25,19;AF=0.41,0.44,0.95;MQM=60;SAP=11;ABP=4	ATP13A2,RP1-37C10.3	synonymous,missense,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon29/29:c.3516G>A:p.Pro1172=:,ATP13A2:ENST00000341676:missense_variant:MODERATE:exon27/27:c.3214G>A:p.Ala1072Thr:,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7136C>T::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon29/29:c.3501G>A:p.Pro1167=:			610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128475 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs3170740	0.3313	0.4703	3029,.	0.2020,0.4851,0.2946,0.5286,0.4630	-2.5490	 ,T(0.32), , 	 ,B(0.00), , 	0.02,0.13		0.24					0.445488375204877	0.4171535938228813	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17313157	17313157	G	A	het	het	hom	off-target	QUAL=9601;DP=83,297,216;AF=0.39,0.50,1.00;MQM=60;SAP=38;ABP=5	ATP13A2,RP1-37C10.3	intron,intron&non_coding_transcript	ATP13A2:ENST00000326735:intron_variant:MODIFIER:intron27/28:c.3236-30C>T::,ATP13A2:ENST00000341676:intron_variant:MODIFIER:intron26/26:c.3103+143C>T::,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7550G>A::,ATP13A2:ENST00000452699:intron_variant:MODIFIER:intron27/28:c.3221-30C>T::		regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	559000 [benign DISEASE=not provided];			rs2076605	0.3468	0.4706	3051,.	0.2188,0.4839,0.2956,0.5242,0.4771	1.8880			0.04,0.13							-0.3906931174998692	0.9415636459494688	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17313245	17313256	CCCAGGGCTCCT	-	het	het	wt	off-target	QUAL=2154;DP=59,210,167;AF=0.39,0.50,0.00;MQM=60;SAP=13;ABP=3	ATP13A2,RP1-37C10.3	intron,intron&non_coding_transcript	ATP13A2:ENST00000326735:intron_variant:MODIFIER:intron27/28:c.3235+44_3235+55del::,ATP13A2:ENST00000341676:intron_variant:MODIFIER:intron26/26:c.3103+44_3103+55del::,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7641_187+7652del::,ATP13A2:ENST00000452699:intron_variant:MODIFIER:intron27/28:c.3220+44_3220+55del::		regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];				rs143483351	0.3059	0.2349	921,.		1.0320							gain/acceptor/17313249-17313248/Medium/9.691849			0.12718192713940552	0.9419822719830643	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17313343	17313343	G	A	het	het	hom		QUAL=10657;DP=92,282,200;AF=0.48,0.49,1.00;MQM=60;SAP=17;ABP=3	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon27/29:c.3192C>T:p.Ala1064=:,ATP13A2:ENST00000341676:synonymous_variant:LOW:exon26/27:c.3060C>T:p.Ala1020=:,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7736G>A::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon27/29:c.3177C>T:p.Ala1059=:		regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128473 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs9435659	0.3385	0.4652	3048,.	0.1875,0.4783,0.2891,0.5225,0.4729	-0.5550			0.07,0.19							-0.09201603195828403	0.9416868244553815	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17313454	17313454	G	A	het	het	wt		QUAL=2298;DP=59,177,138;AF=0.47,0.44,0.00;MQM=60;SAP=32;ABP=8	ATP13A2,RP1-37C10.3	splice_region&intron,intron&non_coding_transcript	ATP13A2:ENST00000326735:splice_region_variant&intron_variant:LOW:intron26/28:c.3084-3C>T::,ATP13A2:ENST00000341676:splice_region_variant&intron_variant:LOW:intron25/26:c.2952-3C>T::,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+7847G>A::,ATP13A2:ENST00000452699:splice_region_variant&intron_variant:LOW:intron26/28:c.3069-3C>T::		regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128471 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs7531163	0.3065	0.2819	997,.	0.1706,0.3596,0.5506,0.2392,0.2307	0.9070			0.66,0.95			9.29>9.90		0.001/0.100		-0.5396885969916893	0.9420504908207213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17313654	17313654	C	T	het	het	hom		QUAL=10644;DP=66,280,245;AF=0.52,0.48,1.00;MQM=60;SAP=151;ABP=3	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon26/29:c.2970G>A:p.Val990=:,ATP13A2:ENST00000341676:synonymous_variant:LOW:exon25/27:c.2838G>A:p.Val946=:,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+8047C>T::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon26/29:c.2955G>A:p.Val985=:		regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128470 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs761421	0.3462	0.4654	3067,.	0.2158,0.4792,0.2830,0.5203,0.4730	-0.9690			0.25,0.72							-0.08033865890540529	0.3903004140981745	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17314702	17314702	C	T	het	het	wt		QUAL=11015;DP=281,583,493;AF=0.48,0.51,0.01;MQM=60;SAP=31;ABP=3	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon25/29:c.2790G>A:p.Ser930=:,ATP13A2:ENST00000341676:synonymous_variant:LOW:exon24/27:c.2658G>A:p.Ser886=:,RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+9095C>T::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon25/29:c.2775G>A:p.Ser925=:		regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128468 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs3738815	0.2909	0.2494	847,.	0.1518,0.3342,0.5507,0.1933,0.2217	-2.3320			0.06,0.15							0.09602596706832822	0.3903004140981745	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17314942	17314942	G	A	het	het	hom		QUAL=14038;DP=300,321,262;AF=0.50,0.45,0.99;MQM=60;SAP=407;ABP=5	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon24/29:c.2637C>T:p.Gly879=:PF12710 [haloacid dehalogenase-like hydrolase],ATP13A2:ENST00000341676:synonymous_variant:LOW:exon23/27:c.2505C>T:p.Gly835=:PF12710 [haloacid dehalogenase-like hydrolase],RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.187+9335G>A::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon24/29:c.2622C>T:p.Gly874=:PF12710 [haloacid dehalogenase-like hydrolase]		regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128466 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs9435662	0.3387	0.4633	3017,.	0.1867,0.4771,0.2888,0.5193,0.4726	-4.7600			0.06,0.67				gain/donor/17314941-17314942/Medium/0.871549			0.2455891074712072	0.09096161262363713	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17319011	17319011	G	A	het	het	hom		QUAL=6537;DP=81,152,126;AF=0.48,0.48,1.00;MQM=60;SAP=55;ABP=3	ATP13A2,RP1-37C10.3	synonymous,intron&non_coding_transcript	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon17/29:c.1815C>T:p.Pro605=:PF12710 [haloacid dehalogenase-like hydrolase],ATP13A2:ENST00000341676:synonymous_variant:LOW:exon17/27:c.1800C>T:p.Pro600=:PF12710 [haloacid dehalogenase-like hydrolase],RP1-37C10.3:ENST00000446261:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.188-12127G>A::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon17/29:c.1800C>T:p.Pro600=:PF12710 [haloacid dehalogenase-like hydrolase]			610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	128465 [benign DISEASE=Parkinson disease 9,History of neurodevelopmental disorder,not specified,not provided];			rs2076603	0.4485	0.5563	4804,.	0.4404,0.5455,0.2863,0.6263,0.5184	0.1640			0.51,0.95							0.2455891074712072	0.2966589250926208	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17331268	17331268	C	T	wt	wt	het		QUAL=642;DP=135,121,74;AF=0.00,0.00,0.41;MQM=60;SAP=3;ABP=8	ATP13A2,RP1-37C10.3	synonymous,non_coding_transcript_exon	ATP13A2:ENST00000326735:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter],ATP13A2:ENST00000341676:synonymous_variant:LOW:exon5/27:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter],RP1-37C10.3:ENST00000446261:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.318C>T::,ATP13A2:ENST00000452699:synonymous_variant:LOW:exon5/29:c.396G>A:p.Ala132=:PF12409 [P5-type ATPase cation transporter]		regulatory_region_variant:CTCF_binding_site	610513 [GENE=ATP13A2 PHENOS=Kufor-Rakeb syndrome,606693,Autosomal recessive/Spastic paraplegia 78,autosomal recessive,617225,Autosomal recessive];	293803 [uncertain significance DISEASE=Parkinson disease 9];			rs140631323		0.0001	0,.	0.0000,0.0001,0.0000,0.0001,0.0002	-4.6690			0.02,0.09						COSM4946978,COSM80893	0.07228987584226187	0.9459948692118021	0	6	0 / 0					ATP13A2(inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	19198064	19198064	T	G	het	het	wt		QUAL=3438;DP=96,185,149;AF=0.52,0.47,0.00;MQM=59;SAP=7;ABP=3	ALDH4A1,RP13-279N23.2	3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:3_prime_UTR_variant:MODIFIER:exon16/16:c.*262A>C::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+2893A>C::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1275A>C::		regulatory_region_variant:enhancer	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294333 [likely benign DISEASE=Hyperprolinemia];			rs1138333	0.1793	0.2342	888,.		1.6090			0.00,0.14							-0.08369979078933901	0.1355315687289665	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1(inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198100	19198100	C	G	het	het	wt		QUAL=3379;DP=94,166,144;AF=0.54,0.49,0.00;MQM=60;SAP=7;ABP=3	ALDH4A1,RP13-279N23.2	3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:3_prime_UTR_variant:MODIFIER:exon16/16:c.*226G>C::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+2857G>C::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1239G>C::		regulatory_region_variant:enhancer	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294334 [likely benign DISEASE=Hyperprolinemia];			rs1138328	0.1651	0.2278	857,.		0.1130			0.00,0.11							-0.10153311995822556	0.1650713054280393	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1(inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198141	19198141	T	C	het	het	wt		QUAL=3385;DP=120,146,139;AF=0.53,0.48,0.00;MQM=60;SAP=4;ABP=3	ALDH4A1,RP13-279N23.2	3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:3_prime_UTR_variant:MODIFIER:exon16/16:c.*185A>G::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+2816A>G::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1198A>G::		regulatory_region_variant:enhancer	606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294336 [likely benign DISEASE=Hyperprolinemia];			rs7366541	0.1799	0.2344	896,.		-1.2020			0.06,0.15							0.15264203718760555	0.1650713054280393	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1(inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198414	19198414	G	A	het	het	wt		QUAL=4514;DP=168,196,168;AF=0.48,0.49,0.00;MQM=60;SAP=26;ABP=3	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:intron15/15:c.*42-130C>T::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+2543C>T::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*925C>T::			606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294341 [likely benign DISEASE=Hyperprolinemia];			rs1140477	0.1935	0.2424	908,.		0.5800			0.12,0.17							0.15264203718760555	0.08017760979620911	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1(inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198418	19198418	C	T	het	het	wt		QUAL=4514;DP=168,196,168;AF=0.48,0.49,0.00;MQM=60;SAP=26;ABP=3	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:intron15/15:c.*42-134G>A::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+2539G>A::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*921G>A::			606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294342 [likely benign DISEASE=Hyperprolinemia];			rs1138269	0.1933	0.2425	908,.		0.1330			0.06,0.16							0.15264203718760555	0.9466470501056532	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1(inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	19198576	19198576	A	G	hom	hom	hom		QUAL=29665;DP=367,313,238;AF=1.00,0.99,1.00;MQM=59;SAP=9;ABP=0	ALDH4A1,RP13-279N23.2	intron,3'UTR,intron&NMD_transcript	ALDH4A1:ENST00000290597:intron_variant:MODIFIER:intron15/15:c.*42-292T>C::,ALDH4A1:ENST00000375341:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,RP13-279N23.2:ENST00000494072:intron_variant&NMD_transcript_variant:MODIFIER:intron22/26:c.*1742+2381T>C::,ALDH4A1:ENST00000538309:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,ALDH4A1:ENST00000538839:3_prime_UTR_variant:MODIFIER:exon14/14:c.*763T>C::			606811 [GENE=ALDH4A1 PHENOS=Hyperprolinemia,type II,239510,Autosomal recessive];	294344 [likely benign DISEASE=Hyperprolinemia];			rs1138267		0.6404	6551,.		-5.8090			0.01,0.12							-0.08143009183925308	0.9561837759100078	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1(inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr22	51065524	51065524	C	A	wt	het	wt	off-target	QUAL=261;DP=18,24,21;AF=0.00,0.71,0.00;MQM=60;SAP=24;ABP=12	ARSA	intron	ARSA:ENST00000216124:intron_variant:MODIFIER:intron2/7:c.466-44G>T::,ARSA:ENST00000356098:intron_variant:MODIFIER:intron3/8:c.466-44G>T::,ARSA:ENST00000395619:intron_variant:MODIFIER:intron3/8:c.466-44G>T::,ARSA:ENST00000395621:intron_variant:MODIFIER:intron3/8:c.466-44G>T::,ARSA:ENST00000453344:intron_variant:MODIFIER:intron2/7:c.208-44G>T::,ARSA:ENST00000547307:intron_variant:MODIFIER:intron2/7:c.460-44G>T::,ARSA:ENST00000547805:intron_variant:MODIFIER:intron3/8:c.460-44G>T::		regulatory_region_variant:promoter	607574 [GENE=ARSA PHENOS=Metachromatic leukodystrophy,250100,Autosomal recessive];				rs6151413	0.0086	0.0153	1,.	0.0035,0.0038,0.0075,0.0175,0.0096	-1.5180			0.05,0.14				loss/acceptor/51065523-51065524/Medium/4.624452			-0.18908294200736026	0.9466413231008122	2	259	0 / 0					ARSA(inh=AR oe_syn=1.02 oe_mis=0.94 oe_lof=0.90)
chr22	51066537	51066537	G	A	wt	het	wt		QUAL=851;DP=137,76,60;AF=0.00,0.54,0.00;MQM=60;SAP=47;ABP=4	ARSA	5'UTR	ARSA:ENST00000216124:5_prime_UTR_variant:MODIFIER:exon1/8:c.-330C>T::,ARSA:ENST00000356098:5_prime_UTR_variant:MODIFIER:exon1/9:c.-177C>T::,ARSA:ENST00000395619:5_prime_UTR_variant:MODIFIER:exon1/9:c.-132C>T::,ARSA:ENST00000395621:5_prime_UTR_variant:MODIFIER:exon1/9:c.-225C>T::,ARSA:ENST00000453344:5_prime_UTR_variant:MODIFIER:exon1/8:c.-198C>T::,ARSA:ENST00000547307:5_prime_UTR_variant:MODIFIER:exon1/8:c.-336C>T::,ARSA:ENST00000547805:5_prime_UTR_variant:MODIFIER:exon1/9:c.-231C>T::		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	607574 [GENE=ARSA PHENOS=Metachromatic leukodystrophy,250100,Autosomal recessive];	342248 [uncertain significance DISEASE=Metachromatic leukodystrophy];			rs558023516	0.0012	0.0068	0,.		-2.1550			0.01,0.07							-0.16047153207691675	0.16668925335436793	0	16	0 / 0					ARSA(inh=AR oe_syn=1.02 oe_mis=0.94 oe_lof=0.90)
chrX	154064580	154064580	T	C	hom	hom	hom		QUAL=10757;DP=114,91,124;AF=1.00,1.00,0.99;MQM=60;SAP=25;ABP=0	F8	3'UTR	F8:ENST00000330287:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1292A>G::,F8:ENST00000360256:3_prime_UTR_variant:MODIFIER:exon26/26:c.*1292A>G::			300841 [GENE=F8 PHENOS=Hemophilia A,306700,X-linked recessive];				rs1396947	0.9926	0.9951	6892,7889		-0.8180			0.00,0.04							-0.16047153207691675	0.0888271539097315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMIM9(inh=n/a oe_syn=0.62 oe_mis=0.81 oe_lof=0.93), F8(inh=XLR oe_syn=0.90 oe_mis=0.76 oe_lof=0.03)
chrX	154488153	154488153	C	T	hom	wt	het		QUAL=7463;DP=181,78,101;AF=1.00,0.00,0.52;MQM=60;SAP=12;ABP=3	RAB39B	3'UTR	RAB39B:ENST00000369454:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1935G>A::			300774 [GENE=RAB39B PHENOS=Mental retardation,X-linked 72,300271,X-linked recessive/Waisman syndrome,311510,X-linked recessive];	368130 [likely benign DISEASE=Non-syndromic X-linked intellectual disability];			rs782447828	0.0005	0.0012	0,12		-1.1200			0.01,0.13							-0.0038247087275311425	0.6850672064845856	1	2	0 / 0					RAB39B(inh=XLR oe_syn=0.85 oe_mis=0.41 oe_lof=0.00)
chrMT	16298	16298	T	C	hom	wt	hom		QUAL=331460;DP=6107,4794,4214;AF=0.99,0.00,0.99;MQM=59;SAP=107;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461:upstream_gene_variant:MODIFIER::::							rs148377232																	283	58	0 / 0					MT-ND4(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16519	16519	T	C	hom	wt	hom		QUAL=371189;DP=7009,4954,4518;AF=1.00,0.01,1.00;MQM=58;SAP=4;ABP=0	MT-ND4,MT-ND5,MT-ND6,MT-CYB,MT-TH,MT-TS2,MT-TL2,MT-TE,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461:upstream_gene_variant:MODIFIER::::							rs3937033																	4521	147	0 / 0					MT-ND4(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP(inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
